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Abstract
Hyperpolarised gas Magnetic Resonance Imaging (MRI) is a non-invasive
method developed to provide images of the void spaces of the lungs, and eval-
uate the distal airways via diffusion weighted techniques. The work in this
thesis covers the use of both hyperpolarised 3He and hyperpolarised 129Xe
gas MRI, for both diffusion measurement studies and ventilation imaging,
on healthy, asthmatic and cystic fibrosis volunteers.
The first study covered in this thesis aimed to determine the nature
of the acinar airway involvement in asthma sufferers via the use of Com-
puted Tomography densitometry and hyperpolarised 3He diffusion MRI at
multiple timescales alongside standard lung function tests such as spirome-
try and multiple breath washout (MBW). It was hypothesised that Asthma
patients with an elevated MBW parameter ’Sacin’ would manifest altered
long-range diffusion, as suggestive of intra-acinar airway disease. It was
found that there appeared to be an association between the MBW Sacin
parameter and subtle alterations in diffusion within the acinar airways for
participants with asthma, suggesting a structural abnormality in the pul-
monary acinus. However, further longitudinal studies are required before
the long-term prognostic significance of acinar airway disease in asthma can
be determined.
i
The second study aimed to determine if a relationship exists between
measurements from standard lung function test, spirometry and body pleth-
ysmography, and the measurements of hyperpolarised 3He diffusion MRI. 18
Cystic Fibrosis patients were recruited, alongside 27 age-matched healthy
subjects. It was found that the short timescale diffusion values were lower
in patients with Cystic Fibrosis, although not substantial enough to use an
indicator to distinguish between a healthy volunteer and a Cystic Fibro-
sis patient. No strong correlations were found between the lung function
measurements and the hyperpolarised 3He diffusion MRI measurements.
The final section of this thesis looks at the preliminary results of a pilot
study to develop scan sequences, protocols and gas delivery of hyperpolarised
129Xe MRI, in preparation for future clinical studies at the University of
Nottingham. The main focus was on the development of in vivo ventilation
images of the human lungs, to a high standard of quality and repeatability.
Good progress was demonstrated, with lung images achieved down to 2.5cm
thick slices, with initial images of both dynamic ventilation and dissolved-
phase 129Xe lung images. However the pilot study was not yet complete,
and more development on the techniques discussed was still required.
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1 Introduction
The motivation behind both hyperpolarised 3He magnetic resonance
diffusion measurements and hyperpolarised 129Xe magnetic resonance imag-
ing is two-fold. Firstly, to improve upon the currently available methods
to diagnose lung disease and monitor disease progression, and secondly, to
add to the current understanding of the physiology and development of lung
diseases in patients via a non-intrusive method.
One of the most common methods for investigating ventilation and
perfusion in the lungs, Computed Tomography (CT), can provide good
anatomical images. However, this comes at a high cost due to the dose
of ionising radiation required by the technique. A typical CT chest scan
may have a dose of 8 mSv, which is approximately equivalent to 3.6 years
of background radiation and a lifetime additional risk of fatal cancer of 1 in
2500 per examination [37].
Other clinical measurements (such as spirometry) are less-invasive, but
assess the lungs as a single global entity. This can be a problem, as the non-
homogeneity of health and disease function across the lung space is well
known.
Magnetic Resonance Imaging (MRI) provides a non-invasive method to
image the body. However traditional MRI uses the hydrogen atoms present
in water, fats and other molecules within the body to provide its signal for
imaging, and as the lungs are essentially mostly air little signal is available to
provide detailed images. There has been efforts to improve upon the useful
1
information extracted via traditional MRI, such as Oxygen-enhanced MRI
[63], however the use of other non-traditional MRI methods can potentially
yield greater results, such as hyperpolarised gas MRI.
This thesis outlines the theory and sequences used in hyperpolarised
3He and 129Xe MR diffusion measurements and imaging. The diffusion mea-
surement techniques detailed are then used to investigate and provide in-
formation on asthma and cystic fibrosis, and the results discussed. The
development of 129Xe lung magnetic resonance imaging at the University
of Nottingham, including ventilation and dissolved-phase imaging, is also
discussed, accompanied by preliminary pilot study results.
1.1 Thesis Outline
Chapter 2 introduces the basic anatomy and mechanics of the human res-
piratory system. This chapter also gives a brief description of the pathology
of the diseases included in the studies discussed in Chapters 5 and 6.
Chapter 3 provides an overview of the basic principles of nuclear magnetic
resonance and magnetic resonance imaging, from the underlying quantum
mechanics, through signal generation and manipulation, to spatial encoding
in MRI. This chapter also provides a brief explanation of diffusion measure-
ments and optical pumping methods.
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Chapter 4 gives an introduction the MRI pulse sequences used in the later
discussed studies, as well as the methods to calculate meaningful results as
applicable. This chapter also gives an overview of the image reconstruction
techniques used by RECON, a GUI program for reconstructing images from
the raw data outputted by MRI scanners.
Chapter 5 applies some of the diffusion measurement sequences discussed
in Chapter 4, alongside Computed Tomography (CT) densitometry and spir-
ometry, to help provide information on the nature of the acinar airway in-
volvement in patients with asthma. This work led to one publication: S.
Gonem et al. [33].
Chapter 6 investigates potential relationships between the measurements
of spirometry and body plethysmography and the measurements taken using
some of the 3He MRI sequences discussed in Chapter 4, on both healthy
volunteers and patients with Cystic Fibrosis.
Chapter 7 looks at the development of 129Xe lung MRI at the Univer-
sity of Nottingham. It shows early results recovered from the pilot study,
included ventilation imaging and dissolved-phase imaging. It ends with a
brief discussion of the future work required on this project.
3
2 The Respiratory System
2.1 Introduction
This section covers the basics of the structure and function of the hu-
man lungs, and a brief overview of the common respiratory diseases encoun-
tered in the studies conducted. For further reading, see [101], [58] or [20].
2.2 Lung Anatomy and Physiology
2.2.1 The Respiratory System
The respiratory system can be divided into two sections: the upper
respiratory, comprising the nasal and oral cavities, pharynx, larynx and
trachea; and the lower respiratory tract, consisting of the main bronchi and
lungs.
The upper respiratory tract is responsible for filtering, warming and
moisturising the air, such that it is in a suitable condition for optimum gas
exchange in the distal parts of the lower respiratory tract. For this purpose,
it has a large surface area with a rich blood supply, and its epithelium (the
tissue lining the cavities and surfaces) is covered by a mucous secretion, with
the nasal hairs acting as a filter.
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The lower respiratory tract is responsible for gas exchange, connecting
to the upper respiratory tract by the two primary bronchi and trachea. The
two bronchi then divide inside the lungs into smaller and smaller airways,
until the final respiratory airways (acinar airways) are reached. These acinar
airways are where the gas exchange takes place.
2.2.2 Lung Development
The lungs first begin to develop approximately 4 weeks after concep-
tion, initially consisting of a longitudinal groove on the side of the primitive
foregut. This then develops into a bud before bifurcating repeatedly. After
about 16 weeks the main conductive airway branching is complete. Dur-
ing weeks 17-28, the basic structure of the acinus develops, as the airways
continue to bifurcate, and the acinar blood vessels begin to develop. In the
following weeks (29-35), further air spaces appear, known as saccules, which
develop epithelium cells similar to that of adult alveoli. True aveoli do not
develop until after 36 weeks, and continue to develop well into the first years
of childhood. At birth, there are only about 24 million terminal sacs and
alveoli, much less than the average adult figure of 300 million alveoli. The
first year of life sees a five-fold increase of alveoli, with slower increases main-
tained after, well up to the 8th year, and perhaps into adolescence [84]. In
the first year of life the airways are also remodelled, with an increase length
of all airway generations, and further branching of alveolar ducts into fur-
ther generations. This suggests a risk that events in infancy and childhood
can lead to lung impairments later in life. In fact, it has been observed
that adults with chronic airflow obstruction had an increased frequency of
respiratory infections during childhood [14,46,77].
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2.2.3 Structure of the Conducting Airways
The conductive airways start at the trachea, and bifurcate down thro-
ugh the generations, getting shorter and narrower as they divide. Table
1 shows the complete airway tree. The conductive airways include all the
Bronchi and Membrane Bronchioles, and finish at the Terminal Bronchioles.
The Respiratory Bronchioles and Alveolar ducts make up the acinus.
The conductive airways do not contain alveoli in their walls, and so
do not participate in gas exchange. Instead they are primarily involved in
conducting the air to the more distal airways. The conductive airways are
lined with cilia, long slender cells up to 6µm in length, and mucous cells.
These act as the first line of defence against potentially harmful agents that
get past the nasal hair filtering.
As the conducting airways do not participate in gas exchange, they
constitute the anatomic dead space, with a volume of about 150 ml.
2.2.4 Structure of the Distal Airways
Alveoli first appear occasionally in the airway walls of the Respiratory
Bronchioles, and increase in number and density in each subsequent gener-
ation until the alveolar duct generations, which are completely lined with
alveoli. These airways are where gas exchange occurs, and are collectively
known as the acinus.
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Table 1: The Weibel Model of the Bronchial Tree
Generation Name
Number of Diameter Length
branches (mm) (mm)
0 Trachea 1 18.0 120.0
1 Bronchi 2 12.2 47.6
2 Bronchi 4 8.3 19.0
3 Bronchi 8 5.6 7.6
4 Bronchi 16 4.5 12.7
5 Bronchi 32 3.5 10.7
6 Bronchi 64 2.8 9.0
7 Bronchi 128 2.3 7.6
8 Bronchi 256 1.86 6.4
9 Membr. Bronchioles 512 1.54 5.4
10 Membr. Bronchioles 1024 1.30 4.6
11 Membr. Bronchioles 2048 1.09 3.9
12 Membr. Bronchioles 4096 0.95 3.3
13 Membr. Bronchioles 8192 0.82 2.7
14 Membr. Bronchioles 16,384 0.74 2.3
15 Membr. Bronchioles 32,768 0.66 2.0
16 Term. Bronchioles 65,536 0.60 1.65
17 Resp. Bronchioles 131,072 0.54 1.41
18 Resp. Bronchioles 262,144 0.50 1.17
19 Resp. Bronchioles 524,288 0.47 0.99
20 Alveolar Ducts 1,048,576 0.45 0.83
21 Alveolar Ducts 2,097,152 0.43 0.70
22 Alveolar Ducts 4,194,304 0.41 0.59
23 Alveolar Ducts 8,388,608 0.41 0.50
Source: [102].
These data are based on a combination of morphometry and assumption.
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The length of each acinus, from the terminal bronchioles to its most
distal alveolus is typically only a few millimetres. Diffusion is the chief
source of the movement of gases through this region. This region makes up
the majority of the lung, with a volume around 2.5-3 L.
The acinar airways comprise the majority of the airway surface area
in the lung [100]. The acinar airways begin at around the 15th branching
generation, and consist of the respiratory bronchioles, alveolar ducts and
alveolar sacks (with alveoli incorporated into the airway walls). Figure 1
shows a diagram of some of the acinar airways, from generation 17 onwards.
Figure 1: Diagram of the Acinar Airways (from generation 17+).
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2.2.5 Lung Ventilation Mechanics
The movement of air in and out of the respiratory system is known as
ventilation. Ventilation can be determined and controlled by the respiratory
rate (number of breaths per minute, typically 12-20) and the tidal volume
(the amount of air that enters the lung with each breath).
When the lung volume is changed (i.e. the expansion or contraction
of the chest) a pressure differential is formed between the inside of the lungs
and the surrounding atmosphere, causing air to move in or out of the lungs
towards the lower pressure area.
The main muscle involved in inspiration is the diaphragm. The di-
aphragm is a dome-shaped muscle upon which the lungs sits, and upon
contraction flattens out. Aiding this are the external intercostal muscles,
which raise the rib cage. The result is an increase in the volume of the chest
(intra-thoracic volume), lowering the air pressure inside, and hence driving
air flow into the lungs.
In comparison, expiration is largely the result of the elastic recoil of
the lung tissue upon relaxation of the intercostal muscles and diaphragm.
However, expiration can be forced (such as during coughing), in which the
internal intercostal muscles are used to lower the rib cage, and the abdom-
inal muscles are used to increase the intra-abdominal pressure, forcing the
abdomen against the diaphragm.
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2.2.6 Gas Exchange Mechanics
The walls of the alveoli contain pulmonary capillaries, with approx-
imately half its surface area having only a 0.2-0.3µm barrier between the
blood and the gas. This provides an ideal location for gas diffusion in and
out of the blood. However, the thin barriers increase the risk that if the
capillary pressure rises to abnormally high levels, or the tension of alveolar
wall is greatly increased (i.e. from inflating the lungs to very high volumes),
the barriers can be damaged.
Simple diffusion drives the movement of gas through the barrier, ac-
cording to the partial pressure differences between the gas area and the
blood. This process can be described by Fick’s law:
dVgas
dt
=
AD
T
(P1 − P2), (1)
where dVgas
dt
is the change in the Volume of gas over time, A is the surface area
available for diffusion, T is the barrier thickness, D is a diffusion constant
(which depends on the properties of the tissue and gas selected), and P1
and P2 are the partial pressures on either side of the barrier. The partial
pressure of a specific gas can be calculated by multiplying its concentration
by the total pressure. The diffusion constant D is inversely proportional to
the gas’s molecular weight, and proportional to the gas’s solubility. This
leads to CO2 diffusing 20 times more rapidly than O2 through the blood-gas
barrier, due to its high solubility.
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2.2.7 Lung Cleaning Mechanics
The lungs have a variety of defences and methods to keep them clean.
The nasal hairs help to filter out the larger particles, preventing them from
entering the lungs. Smaller particles are captured by the mucus that lines the
conductive airways, secreted by the epithelial cells there. Once captured the
mucus (and captured particles) are expelled via two methods. The first, and
fastest, method is to cough. During a cough high air velocities are reached
in the conductive airways, which is sufficient to remove mucus and particles
from the smaller airways. The second method is much slower, where the
small finger-like protrusions known as cilia which line the conductive airways
continually waft, gradually carrying the mucus and particles up towards the
oesophagus to be swallowed. The final lung cleaning mechanism deals with
the very smallest particles, that make it all the way to the alveoli. Once
there they are deposited on the alveoli lining, and are engulfed by large cells
known as macrophages. The particles are then removed via the circulatory
or lymphatic system.
2.3 Lung Pathology
2.3.1 Asthma
Bronchial asthma (aetiologically distinct from cardiac asthma) is a
condition in which breathing is intermittently difficult, due to narrowing
of the bronchi. Bronchial asthma (hereafter referred to as just asthma) is
characterised by episodic ’attacks’, consisting of wheezing, tightness of the
chest, shortness of breath and coughing. During exhalation the effect of an
asthma ’attack’ is more noticeable, as this is the respiration phase where the
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airways normally collapse, and because the muscles involved in expiration
are weaker than the muscles involved in inspiration.
There are two types of asthma, extrinsic and intrinsic. Extrinsic
asthma is associate with an exposure to a wide range of allergens, such
as fur, feathers, pollens, or house dust mites. It is the most common of the
two asthma types, and usually begins in childhood, and tends to become
less severe with age, though some continue to have symptoms in adult life.
Intrinsic asthma is not associated with an external stimuli, and is most often
onset in adult life. It is chronic, tending to worsen with age.
The narrowing of the airways has been seen to be caused primarily
by three processes: increased amounts of mucus, inflammatory oedema (in-
flammation due to fluid build-up in the cells) and muscular hypertrophy
(the increase in size of muscle cells). These three processes are found to
occur mainly in the bronchi, but can also be found in the smaller airways,
including the bronchioles. The alveoli may also be involved [52].
There are many trigger factors for both extrinsic and intrinsic asthma,
via either an inflammatory or neurological mechanism. Asthmatics are usu-
ally over-responsive to irritant dusts, respiratory infection and large volumes
of cold dry air (such as experienced during outdoor exercise, or during win-
ter). Emotional stress can also be a triggering factor in asthma.
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Asthma can be managed quite effectively by avoidance of the identified
triggers, with the use of bronchodilator drugs and corticosteroids as required.
Breathing exercises and desensitisation to specific allergens are often supple-
mented alongside. Recently other treatments have been developed, including
leukotriene and leukotriene receptor antagonists, antibodies directed against
IgE, and the identification of several genes relating to asthma, suggesting
that a gene therapy treatment may be developed at a future date.
2.3.2 Cystic Fibrosis
Cystic Fibrosis is a genetically inherited condition characterised by
abnormal secretions. Only as little as 50 years ago a cystic fibrosis patient
was not expected to live past the first year of life, whereas now most can
be expect to survive until the fourth decade of life. It is reported across all
racial groups, although it is more common in Caucasian people (in the UK 1
in 2500 are born affected, with 1 in 25 carrying the the responsible recessive
gene).
The genetic abnormality affects a protein known as Cystic Fibrosis
Transmembrane Conductance Regulator (CFTR), which helps control ion,
and hence water, movement across the cell membrane. This results in ex-
cessive re absorption of water, leading to the hyper-viscosity of mucus and
hyper-salinity of sweat and mucosal secretions.
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The hyper-salinity impairs the antibacterial action of constituents such
as lactoferrin and lysozyme in the airways, and when combined with the
difficulty in clearing the hyper-viscous mucus leads to permanent infections
and inflammation of the respiratory tract. The hyper-salinity and hyper-
viscosity resulting from the defective CFTR gene can also affect the Cystic
Fibrosis sufferer in other areas of the body, such as the reproductive system
and pancreas.
Repeated pulmonary infection remains the major clinical problem in
Cystic Fibrosis, despite improvements in patient care, with the cause of
death in adults usually being bronchopulmonary infection, respiratory failure
and cor pulmonale (abnormal enlargement of the right side of the heart).
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3 NMR, MRI and Polarisation
3.1 Nuclear Magnetic Resonance
3.1.1 Introduction
This section provides a concise overview of the theory behind Nuclear
Magnetic Resonance (NMR), but is in no means a complete review. A
complete explanation of all the basic principles already exists in many texts
elsewhere [51] [53] [31].
NMR is based on the magnetic properties of the atomic nucleus, due
to its proton and neutron components. The Hydrogen nucleus (also referred
to as proton or 1H) is the most common target of NMR, due to its relatively
high thermal polarisation at room temperature, and its abundance in the
human body ( 63% by atomic count [22]).
3.1.2 Nuclear Spin and Angular Momentum
Nuclei lie at the heart of NMR, and consist of two particles, protons
and neutrons. These particles have many properties, but the most signifi-
cant, at least to NMR, is their intrinsic spin and electric charge.
Intrinsic spin is quantum mechanical in nature, but can be visualised
as the rotation of the particles as it is a form of angular momentum. The
total spin angular momentum of a particle with spin takes the form of [S(S+
1)]1/2h¯, where S is the spin quantum number. Protons and neutrons, being
fermions, have half-integer spins, or more specifically, have spin=1/2.
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The total spin angular momentum of a system comprising more than
one particle, such as a nucleus, is given by [Sn(Sn + 1)]
1/2h¯, where Sn can
take one of multiple forms, arising from the addition or subtraction of the
individual particle’s spin. For example, in a two-particle system, Sn can take
one of the following possible values:
Sn =

|S1 − S2|
|S1 + S2|
(2)
In the case of two particles with half-integer spin, i.e. S1 = S2 = 1/2,
there are only two possibilities for the total spin angular momentum, either
Sn = 0 or Sn = 1. This often expressed as ”opposing spins” where the spins
cancel out to make Sn = 0, or ”parallel spins” where the spins add to make
Sn = 1. The different states that Sn are dependant on the energy of the
system. The lowest energy is often referred to as the Ground state.
Figure 2: Diagram representing the total spin energy levels of a 2H
nucleus.
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In the case of nuclei, the combination of the spins of the protons and
neutrons is known as Nuclear Spin, and is conventionally denoted I. For
example, in the case of the nucleus of 1H, which consists of just one proton,
has only I = 1/2, whereas the nucleus of 2H, consisting of a proton and a
neutron, can have either I = 0 or I = 1. The energy difference between
the two spin states is 1011kJmol−1, which is vastly surpasses the energies
available in standard chemical reactions, electromagnetic fields, or thermal
energy at room temperature, hence the higher state (Sn = 0) is only ever
seen in exotic circumstances. Again, the value of I of the lowest energy is
called the ground state nuclear spin. There is generally no simple rule for
determining which of the states is the ground state.
3.1.3 Zeeman Splitting
A spin I nuclear state is degenerate, by (2I + 1), and this degeneracy
is broken if a magnetic field is applied. This splitting is known as nuclear
Zeeman splitting. It is these nuclear Zeeman sub-levels that provide the
NMR spectroscopy.
3.1.4 Magnetic Moment and Larmor Frequency
The nuclear magnetic moment, like spin, is an intrinsic quantum me-
chanical property. The magnetic moment and spin angular momentum are
closely linked, and are proportional to each other:
µ = γS (3)
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where µ is the magnetic moment, and γ is the gyromagnetic ratio. This
is usually specified in units of rads−1T−1, and can be either positive or
negative, where a negative value means that the direction of the magnetic
moment is in the opposite direction of the spin angular momentum. As with
spin, the magnetic moment of a nucleus is derived from its particles. The
gyromagnetic ratio of common atomic nuclei can be seen in Table 2.
Table 2: Selection of Nuclear Isotopes for NMR.
Isotopes
Ground-State
Nuclear Spin
Natural
Abundance (%)
γ
(106rads−1T−1)
1H 1/2 99.99 267.513
2H 1 0.012 41.065
3He 1/2 * 203.789
7Li 3/2 92.41 103.962
13C 1/2 1.07 67.262
17O 5/2 0.038 36.264
31P 1/2 100 108.291
129Xe 1/2 26.44 73.997
*: 3He obtained from tritium decay.
Sources: [8, 99,104].
Just as classical angular momentum is a vector, so is the angular mo-
mentum of a particle with spin. Hence it can point in any direction in space,
and its direction is often referred to as the spin polarization axis. Generally,
particles with spin have their axes pointing in all possible directions. The
magnetic moment of a particle is also a vector, and can either point in the
same direction as the spin polarization axis or against it, depending on its
γ value.
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When a magnetic field is applied, it would be expected that the par-
ticles rotate to align the magnetic moment with the field, and reduce the
magnetic energy. However, the spin vector actually moves around the field,
on a cone, with a constant angle between the magnetic moment and the field
(see 3). This is known as spin precession. This behaviour is due to the fact
that the particles have angular momentum as well as a magnetic moment.
The frequency of the precession (ω0) is given by:
ω0 = −γB0 (4)
where B0 is the applied magnetic field and γ is the gyromagnetic ratio as
before. In the case of nuclei, the frequency of precession is known as nuclear
Larmor frequency. It is usually expressed as an angular frequency with
units of rads−1. As γ can be either positive or negative, so can the Larmor
frequency. Its sign represents its direction of rotation, with a negative value
representing a precession in the anti-clockwise direction, when seen looking
up along the direction of the magnetic field.
3.1.5 Spin-Lattice Relaxation and Net Magnetisation
As mentioned before, in the absence of a magnetic field the spin direc-
tions of nuclei are uniformly distributed in space, and when the the magnetic
field is applied, they begin to precess around it, at uniformly distributed an-
gles from their initial starting positions. At this point, the net magnetic
moment of the particles is close to zero, as the contributions from individual
spins approximately cancel each other out.
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Figure 3: Diagram of Spin Precession
However in the case of the 1H nucleus, for example in a typical sample
consisting of water molecules, it is not that simple. The molecule is full of
magnetic particles, such as electrons and the neighbouring nuclei. These are
all sources of very small local magnetic fields that are fluctuating in both
magnitude and direction, due to thermal agitation. So the spin precession
of a single nucleus at any given moment may vary slightly in both frequency
and direction to that of its neighbouring nuclei.
Over time this leads to the spin polarization to have a ’wandering’
motion. The time-scale for this is often in seconds. However this wandering
motion is not entirely isotropic, as the finite temperature of the environment
means that there is a slightly higher probability that the wandering motion
will move towards alignment with the applied field, rather than against
it. This bias eventually leads to a thermal equilibrium, with a stable dis-
tribution of nuclear spin polarization favouring the field alignment. This
distribution is stable on a macroscopic scale, as the individual nuclei have
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still got wandering spin polarizations. This net distribution of spin polar-
ization orientations, and therefore magnetic moments, leads to a small net
magnetic moment across the sample in the direction of the field, known as
the total magnetisation. The process of magnetisation growth is known as
longitudinal relaxation, or Spin-Lattice relaxation, where longitudinal term
indicates that it is occurring along the applied field axis. The lattice term
is derived from the early days of NMR and refers to all the constituents of
the sample surrounding the spin, and the term relaxation is used to describe
the re-establishment of a thermal equilibrium.
When a field is first applied, the net magnetisation is zero. The gradual
build up of the magnetisation due to this spin-lattice relaxation is approxi-
mately exponential, and has the form:
Mz(t) = Meq(1− e−t/T1) (5)
where Mz is the net magnetisation in the z-direction (along the applied
magnetic field) at time t, Meq is the net magnetisation in the z-direction at
thermal equilibrium, and T1 is a time constant known as either spin-lattice
relaxation time constant or longitudinal relaxation time constant.
3.1.6 Rotating and Detecting the Magnetisation
When the magnetisation is aligned with the applied magnetic field, it
is almost undetectable, as it is around four orders of magnitude less than
the diamagnetism of the sample, originating from its electrons. So the mag-
netisation perpendicular to the applied field is measured.
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As described in the previous section, a sample comes to thermal equi-
librium and has a net magnetisation in the z-direction (along the applied
magnetic field). However it still has a random distribution of magnetisation
in the x and y directions, leading to a zero net transverse magnetisation.
However a radio frequency pulse (r.f. pulse) can be applied along another
axis to rotate the magnetisation into the transverse plane.
A coil that is wound around the x-axis and has r.f. power supplied
to it produces an oscillating magnetic field along the x-axis. This field is
represented by the symbol B1, and has a frequency of ωtx, where the tx
signifies that it is transmitted along the x-axis.
When the spin system is looked at in a rotating frame around the z-
axis, instead of the laboratory frame, the effective magnetic field of both the
static and oscillating field changes. Taking a rotating frame frequency ωrot,
and the Larmor frequency of the spin precession ω0, we have a frequency
offset Ω, of:
Ω = ω0 − ωrot (6)
If we place this and rearrange the equation for the frequency of preces-
sion around a magnetic field (equation 4), we find that we get an expression
for the apparent, or reduced, field ∆B:
∆B = −Ω
γ
(7)
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It can be seen from this that as the frequency of the rotational frame
approaches the Larmor frequency, the reduced field goes to zero.
As for the oscillating field, if the frequency of the oscillating field
matches that of the rotating frame, then it appears as a constant field in
the x-axis. Hence in a rotating frame of frequency ωrot = ωtx we have the
reduced field in the z-direction and the B1 along the x-axis, which add vec-
torially to give an effective field Beff , of magnitude:
Beff =
√
B21 + (∆B)
2 (8)
Just as there is a precession around the B0 field in the Laboratory
frame, there is a precession around the Beff field in the rotating frame. As
usual, the frequency ωeff of this precession is given by:
ωeff = |γ|Beff (9)
In this case we take the absolute value of γ such that ωeff is always
positive. If the offset Ω is small, the Beff will lie close to the x-axis, and
so the magnetisation will be rotated out of the z-axis. For the case of an
on-resonance pulse (i.e ωrot = ωtx = ω0), we see the reduced field will go to
0, so Beff will be equal to B1, and so we define the precession frequency
as ω1 = |γ|B1. So if an on-resonance pulse is applied, for time tp, the
magnetisation is rotated by an angle of β radians:
β = ω1tp (10)
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where β is known as the flip angle of the pulse. So if the pulse length is set
such that β =
pi
2
, then the net magnetisation will now be along the y-axis (of
the rotating frame). Hence in the Laboratory frame, the net magnetisation
is now rotating in the transverse plane at the Larmor frequency, and can be
detected by the placing of a ’receive’ coil near the sample, where it induces
an oscillating emf which can be amplified and detected.
After an rf pulse has been applied, and the magnetisation rotated into
the x-y plane, it will begin to decay back towards the z-axis due to spin-
lattice relaxation, as described earlier.
3.1.7 Transverse Relaxation
After a rf pulse is applied, and the spins rotated into the x-y plane,
a signal can be detected in the receive coil. However this signal will soon
begin to decay, over a shorter time then expected for spin-lattice relaxation.
This is due to transverse relaxation.
Immediately following the B1 rf pulse the spins are in phase, adding
up to a net rotating magnetisation. As discussed in the previous section,
the microscopic field is always slightly fluctuating, meaning that each spin is
precessing at a slightly different rate. This leads to a dephasing of the spins,
reducing the macroscopic magnetisation along the x-y axes. Eventually the
spins will dephase enough such that they are all randomly distributed, pro-
ducing a net transverse magnetisation of zero.
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The macroscopic field (split into components x and y), at time t after
a 90◦pulse is given by:
Mx(t) = Meqsin(ω0t)e
−t/T2 (11a)
My(t) = −Meqcos(ω0t)e−t/T2 (11b)
where Meq is the magnetisation in the z direction at thermal equilibrium
before the pulse, and T2 is the transverse relaxation time constant.
Often in practice the applied field is not perfectly homogeneous, or
there may be localised magnetic material in or near the sample which gives
rise to a non-homogeneous field across the sample. This will cause transverse
relaxation to occur faster, due to a smaller time constant. In this case,
the time constant of the decay is denoted as T ∗2 , to represent that it is a
combination of both the microscopic field fluctuations, which leads to an
irreversible decay, and macroscopic field inhomogeneity, whose effect can be
reversed with a spin echo (see next section).
The oscillating signal and subsequent decay of signal in the receive
coil after a pulse is referred to as a an NMR signal, or free-induction decay
(FID).
3.1.8 The Spin Echo
The spin echo sequence is one of the basic types of pulse sequences,
where a FID signal is generated by applying a rf pulse (usually
pi
2
), allowed to
dissipate due to T ∗2 decay or forced to dissipate due to applied field gradients,
and some of the decay reversed by the application of a 180◦ pulse.
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Figure 4: Decay of the NMR signal over time due to Transverse
Relaxation
Fig 10 illustrates the effect that a 180◦ pulse has on the transverse
magnetisation. As can be seen, the signal is generated by the first application
of a pulse (in this case 90◦), and then is lost as the spins go out of phase due
to inhomogeneities in both the local and applied fields. Then when the 180◦
pulse is applied along the x-direction, the spins are rotated 180◦ around the
x-axis. The process that originally de-phased them then returns them back
into phase, and a signal is seen (known as a spin echo).
The amplitude of the echo seen is lower than the original FID, due
to T2 decay that has occurred during the time taken to create the echo. A
shorter time period between the original production of the signal and the
creation of the echo (know as the echo time, Te) results in a larger echo
signal. By varying the echo time, the spin echo can be used to measure T2.
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Figure 5: Illustration of the Spin Echo Process
a) Following an rf pulse the spins are initially in phase with each other, producing an
FID. b) After time τ , the spins have precessed at different rates, and are no longer in
phase, so there is no signal. c) After a 180◦ pulse, the spins are flipped around the
x-axis. d) The spins precess at the same rate as before, causing the signal to return
after time τ .
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3.2 Magnetic Resonance Imaging
3.2.1 Introduction
This section explains how useful information and/or images can be
extracted from the NMR signal as described in the previous section. This is
an overview, as more details can be found in texts elsewhere [59] [53] [51].
3.2.2 The Magnetic Gradient
The magnetic field gradient is another important part of both NMR
and MRI sequences, alongside the main applied magnetic field B0, and the
rf pulse B1. As its name suggests, the gradient alters the B0 field, such that
it increases across one dimension, usually with the original B0 field strength
in the centre of the magnet.
As equation 4 describes, the spin precession is dependant on the B0
field strength, and so when a gradient is applied across a certain dimension,
the Larmor frequency of the spins varies across the same dimension. Figure
7 shows the relationship between the magnetic field (with gradient applied
across the x-dimension), and the frequency of the precession of the spins
across the x-dimension. This effect means that gradients can be a useful tool
for manipulating the spins, and hence the NMR signal. A prime example of
this is the gradient echo.
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3.2.3 The Gradient Echo
The gradient echo is one of the basic types of pulse sequences, where
an NMR FID signal is generated via an r.f. pulse, then a gradient is applied
to dephase the spins, followed by an equal but inverted gradient is applied
to re-phase the spins, generating an echo.
Figure 6: Illustration of the Gradient Echo Process
a) Following an rf pulse the spins are initially in phase with each other, producing an
FID. b) With the application of a gradient, the spins precess at different rates, and are
no longer in phase, so there is no signal. c) With time, inhomogeneities in the local and
external fields have caused the spins to go out of phase further. d) After the application
of a second, inverted gradient, the spins precess at different rates and return into phase,
causing the signal to return (though slightly lessened due to the de-phasing caused by
the inhomogeneities.
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Fig 6 illustrates the effect that the two gradients have on the transverse
magnetisation. As can be seen, the signal is generated by the first application
of a pulse (in this case 90◦), and then is lost as the spins go out of phase
due to the first applied gradient. Then when an inverted but equal strength
gradient is applied the process that originally de-phased the spins returns
them back into phase, and a signal is seen (known as a gradient echo).
As for spin echo, the amplitude of the echo seen is lower than the orig-
inal FID, due to T2 decay that has occurred during the time taken to create
the echo. However, unlike for spin echo, the gradient echo is also reduced
due to de-phasing by the inhomogeneities in the field. The combination of
this with T2 leads to a faster decay constant, known as T
∗
2 . As for spin echo,
a shorter time period between the original production of the signal and the
creation of the echo (known as the echo time, Te) results in a larger echo
signal. By varying the echo time, the gradient echo can be used to measure
T ∗2 .
3.2.4 Fourier Transform and Frequency Encoding
As was discussed in the previous section, when a gradient is applied,
the spins precess at various speeds. If the gradient is applied during the
signal acquisition, the data acquired will consist of a combination of the
various frequencies and their relevant intensities. This technique is known
as frequency encoding.
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Fourier transformation can be used to convert the time-domain data
into the frequency-domain. The time-domain data is known as k-space data,
as the intensity at various points does not directly correspond to a physical
dimension, whereas the frequency-domain data does. Due to the applied
gradient the spin precession frequency varies across a single dimension. The
physical offsets can be calculated from the frequency offset (as long as the
gradient strength is known) from manipulating equation 4.
ω0 + δω = γ(B0 +Gxδx) (12)
ω0 + δω = γB0 + γGxδx (13)
δx =
δω
γGx
(14)
where δω is the frequency offset from the pulse frequency ω0, Gx is the applied
gradient strength across the x-dimension, and δx is the physical offset of the
sample from the centre point of the applied gradient.
3.2.5 Phase Encoding
Frequency encoding, as discussed in the previous section, provides a
way to gather spatial information in a single dimension. To acquire infor-
mation for two dimensions requires an extra set of gradients, that provide
phase encoding, across multiple acquisitions.
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Figure 7: Illustration of the gradient magnetic field and spin
precession relationship.
For phase encoding a gradient is applied just before each acquisition,
with a different strength each time. This gradient is applied in a perpendic-
ular direction to the frequency encoding gradient, and the effect is to cause
the spins to go out-of-phase with each other, along that one direction. By
varying the strength of the gradient, the phase shift changes each time. At
the end, a 2-dimensional Fourier Transformation can be applied to the re-
sulting 2-dimensional k-space data, recovering both the frequency and phase
information, which corresponds to 2-dimensional real space.
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3.2.6 Slice Selection
Using the Frequency encoding and Phase encoding, it is possible to get
a 2-dimensional image of the sample. However, this 2-dimensional image is
a conglomeration of the entire sample in the remaining direction. To limit
the ”thickness” of the remaining dimension that contributes to the image,
known as a slice, a technique known as slice selection is used.
Slice selection works in a similar way to frequency encoding, except
the gradient is applied during the initial rf pulse. A gradient, applied in
the remaining dimension not used by either frequency or phase encoding
gradients, is applied for the duration of the rf pulse. As the Larmor frequency
of the spins is dependent on the magnetic field strength, only those spins that
are within the bandwidth of the rf pulse are excited. Hence by controlling
the gradient strength, rf pulse frequency and RF pulse bandwidth, a single
’slice’ of the sample, at a specific thickness and at a specific position can be
selected. Once done only this ’slice’ will have been rotated into the transverse
plane, and hence only this slice will contribute to the NMR signal.
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3.3 Diffusion Measurements
3.3.1 Gas Diffusion
The net movement of molecules (or atoms) from a high concentration
area to a low concentration area is known as diffusion. Diffusion is considered
the result of a ’random walk’ of the diffusing particles.
The ’random walk’ is the seemingly random motion of an individual
atom, ion or molecule through space. However the molecule is not truly
moving randomly, but instead its motion is the result of ’collisions’ with
other atoms, ions or molecules, and only appears to be moving randomly
when viewed in isolation. ’Random walk’ is governed by the kinetic energy
within the system, and is affected by changes in concentration, pressure and
temperature. The random motion of particles in a fluid (liquid or gas) due
their collisions is also known as Brownian motion.
For an unrestricted sample (where molecules are able to move freely),
then the displacement of particles in one direction is the equal to the dis-
placement of particles in all other directions. When considering only a single
dimension, the mean squared displacement (x¯2) for a given particle in a sam-
ple after a time t is given by:
x¯2 = 2Dt (15)
where D is the diffusion coefficient of the sample in question. This means
that if displacement of particles in a sample can be measured, the diffusion
coefficient of the sample can be calculated.
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However if the sample is in restricted space, such as for gas in the air-
ways of the lungs, the mean displacement of a particle is reduced, and hence
the measure diffusion coefficient is lower than that for the unrestricted space.
This lowered diffusion coefficient is sometimes known as Apparent Diffusion
Coefficient (ADC). The more restrictive the space, the lower the measured
ADC will be compared to the sample unrestricted diffusion coefficient.
3.3.2 Measuring Diffusion in MRI
The diffusion of liquids and gases in a sample is sometimes of interest
to researchers, and can be probed using MRI.
To probe the diffusion of a liquid or gas, a pair of diffusion weighting
gradients are used. The diffusion gradients consist of one gradient to de-
phase the spins, and another of equal area but opposite direction to re-
phase the spins. A prime example of this is the Pulsed Gradient Spin Echo
sequence, shown in Figure 8 Any spin that moves (due to diffusion) during
that time will not experience the correct re-phasing magnetisation, and so
will not contribute to the final NMR signal, reducing the overall signal.
The effect on the signal intensity by diffusion weighting (ignoring other
effects such as relaxation) can be described by:
S = S0e
−bD (16)
where S is the signal seen, S0 is the signal intensity without diffusion weight-
ing gradients, D is the diffusion coefficient of the sample, and b is the b-value,
a term expressing the amount of diffusion sensitivity applied by the gradi-
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Figure 8: Illustration of the pulsed gradient spin echo (PGSE)
sequence.
ents. The b-value is expressed as:
b = γ2G2δ2(∆− δ
3
) (17)
where γ is the gyromagnetic ratio, G is the strength of the applied gradient
fields, δ is the length of the time each gradient lasts, and ∆ is the time
between the de-phase and re-phase diffusion weighting gradients.
Graph 9 shows the theoretical signal strength of two Spin Echo se-
quences, one without any diffusion weighting gradients, where the decrease
in signal strength over time is due to T2 decay alone, and the other with
diffusion weighting gradients, where the decrease in signal strength over time
is due to both T2 decay and diffusion.
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Figure 9: Signal Decay due to T2 and Diffusion.
Graph showing signal decay due to T2 compared to signal decay due to T2 and diffusion.
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3.3.3 The Yablonskiy Model Approach
In 2008, Yablonskiyy et al. introduced a model-based method to pro-
vide quantitative valujes of physiological parameters from a single hyper-
polarised 3He MRI scan [109]. The approach is based on a model of lung
gemoetric structure, where lung acinar airways are treated as a network of
cylindrical passages. Each of these passages are covered with alveolar sleeves.
The main geometric parameters characterising these airways are the internal
acinar airway radius r, the sleeve width h, the outer acinar radius R (where
R = r + h), and the effective alveolar diameter L. In the model adopted
by Yablonskiiy et al., each alveolus occupies one-eighth of the annular ring,
and hence L is related to R by L = 2Rsin(pi/8).
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Figure 10: Schematic of an Acinar Airway for the 8-Alveolar
Cylindrical Lung Model
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Equation 16 for signal attentuation assumed that the Diffusion coeffi-
cient was constant regardless of the direction study. However as the alveolar
walls, alveoli wells, and other branches of the airway tree each serve as ob-
stacles to diffusing atoms, the restrictions are substantially less along the
airway axis than perpendicular to it. Therefore, the measured diffusion co-
efficient (from here on known as the Apparent Diffusion Coefficient, ADC)
depends on the angle between the airway’s principle axis and the direction
of the diffusion-sensitising gradient (α):
S = S0e
−bADC(α), (18)
which, due to the cylindrical symmetry of the airways in the model, can be
split into longitudinal and transverse diffusion coefficients (DL and DT ):
ADC(α) = DL cos
2(α) +DT sin
2(α) (19)
The lung consists of a large number of acinar airways, all in different
orientations. Even in each voxel of an MRI scan, there a large number
of airways, such that the orientation distribution function can be taken as
uniform. This means that the signal attenuation for each b-value can be
written as [108]:
S(b) = S0e
−bDT pi
4bDAN
1/2
Φ[(bDAN)
1/2], (20)
where DAN = DL −DT and Φ(x) is the error function. The validity of this
equation was confirmed in vivo by experimental measurements in humans
[107, 109], canines [81], mice [65, 95] and rats [45, 106] using hyperpolarised
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3He gas MRI.
To infer lung micro-structure physiology from the measured diffusion
coefficients DL and DT , their dependencies on the geometric parameters R
and h must be found. These were achieved by means of computer Monte-
Carlo simulations [81]. The results were summarised as:
DL = DL0 (1− βL bDL0)
DT = DT0 (1 + βT bDT0)
DL0
D0
= e−2.89(h/R)
1.78
βL = 35.6(R/L1)
1.5e
−4√
h/R
DT0
D0
= e−0.73(L2/R)
1.4
(1 + e−A(h/R)
2
(e−5(h/R)
2
+ 5(h/R2)− 1))
A = 1.3 + 0.25e14(R/L2)
2
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3.4 Polarisation of Noble gases
3.4.1 Introduction
There are many other nuclear isotopes other than 1H that have a non-
zero Nuclear Spin ground-state, and therefore will produce an NMR signal
(see Table 2). Of particular interest are those that are non-toxic and in
gaseous form, as they can be used to fill the normally ’empty’ region of
the lungs for MRI scans. However before they can be used, they must
have a high enough magnetisation in order to get a good NMR signal. The
magnetisation (M0) produced by a sample of any of these isotopes is given
by [36]:
M0 =
1
2
NSγh¯P, (21)
where Ns is the number of nuclear spins, and P is the polarisation, i.e. the
proportion of the nuclear spins in a sample that occupy the same state at
thermal equilibrium. The polarisation is dependant on temperature (T ) and
the applied magnetic field (B0) [36]:
P = tanh(
γh¯B0
2kT
), (22)
where k is Boltzmann’s constant. Due to the relative weakness of nuclear
magnetic moments, it is generally true that γh¯B0/kT  1, which yields:
P ≈ γh¯B0
2kT
. (23)
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For example, a sample of protons at room temperature in a field of
1.5 T have P ≈ 5.23 × 10−6%. A sample of 129Xenon nuclei would only
have a little less, P ≈ 1.45 × 10−6%. However, Xenon is a gas at room
temperature, so its spin density is vastly lower, so a sample of the same
volume would be several orders of magnitude less. This presents a problem,
as from equations 21-23 it can be seen that to increase the magnitude at
thermal equilibrium, one would have to either increase B0, which becomes
increasingly more expensive and difficult, or by decreasing T drastically,
which would be inappropriate for various samples, such as those involving
living organisms.
Instead, a sample can achieve higher nuclear polarisation by raising it
to a non-equilibrium state. The sample would then succumb to spin-lattice
(T1) relaxation, but provided that any useful experiments are performed
faster than this relaxation, a stronger NMR signal can be detected for the
duration of the experiment/s.
Optical pumping is one such method for attaining high non-equilibrium
nuclear spin polarisations, and can provide an increase of magnetisation by
four of five orders of magnitude. Kastler [13,49] first showed that circularly
polarised light could be used to polarise the electronic spin states of gaseous
metal vapours, and via hyperfine coupling polarise the nuclei states as pos-
tulated by Overhauser [66]. Bouchiat [9] and Grover [38] then showed that
via collision and spin exchange the nuclear spin-polarised alkali atoms the
polarisation of the nuclear spins of noble gases could be greatly enhanced.
Later a second method called metastability exchange optical pumping was
developed [7,18,27,80], for pumping helium directly without the presence of
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alkali metal atoms.
The following sub-sections contain a brief summary of the two methods
for optically pumping noble gases, as used on 129Xe and 3He.
3.4.2 Spin Exchange Optical Pumping
In 1950 Kastler [49] first showed that circularly polarised light could
be used to polarise the electronic spin states of gaseous metal vapours, and
soon after it was found that hyperfine coupling [66] will lead to a polarisation
of the nuclear spin states as well [23, 30]. It was not until 1960 that the
technique of nuclear polarisation of the noble gas 3He via spin exchange
with optical pumped rubidium was developed [9], and then refined over
time to include all the stable noble gas isotopes [38]. The process involved
is described below, using the example of polarising the nucleus of 129Xe with
Rubidium as the alkali metal.
First circularly polarised resonant light, focussing on theD1 absorption
line, is used to excite the 85/87Rb 52S1/2 electronic ground state to the 5
2P1/2
first excited state, according to the selection rule ∆m = +1 (see Figure 11).
Hence, electrons in F = 2,m = −2 ground state can only be excited to F =
2,m = 1 of the excited state, and similarly electrons in F = 2,m = −1, 0, 1
can only be excited to F = 2,m = 0, 1, 2 respectively. From the excited
state, the electrons decay to all ground states with equal probability. The
net result is depletion of ground state 85/87Rb atoms in the lower magnetic
quantum numbers, and an increase of ground state 85/87Rb atoms in the
highest magnetic quantum number.
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Figure 11: Representation of the rubidium electronic energy levels,
and the transitions involved in spin exchange optical pumping.
Figure 12: Diagram of the Rb-Xe spin exchange collision.
Electronic polarisation is donated by a *, and nuclear spin state is represented by an
arrow.
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Spin-exchange optical pumping is most often performed at high pres-
sures, to increase the number of collisions between the 85/87Rb and the 129Xe
and N buffer gasses. Some of these collisions are undesirable, due to spin
destruction, but others are useful as they provide the transfer of polarisa-
tion from the 85/87Rb electrons to the 129Xe nuclei. This transfer of angular
momentum is a consequence of the Fermi contact hyperfine interaction. See
Figure 12 for an illustration of the interaction.
In ideal conditions, with perfect polarisation transfer and minimum
spin destruction collisions, the 129Xe nuclei polarisation will tend towards
the level of polarisation of the 85/87Rb electrons.
3.4.3 Metastable Optical Pumping
In 1960 a new technique for the optical pumping of the metastable
state of 4He was developed [17]. Then in 1962, the technique was applied to
3He, and was found to also polarise the nuclei of the ground state 3He [18].
The energy levels and excitations involved for the optical pumping of
the metastable states of 4He and 3He can be seen in Figure 13. When a
low-pressure sample has a rf discharge placed across it, a small fraction of
the atoms are excited from the 11S0 electronic ground state to the long-lived
23S1 electronic metastable state (label 1). Circularly polarised light can then
be used to excite from the 23S1 to the 2
3P0 electronic states, according to
the selection rule ∆m = +1 (label 2). So the circularly polarised light only
excites atoms from the metastable m = −3/2 and m = −1/2 sub-levels to
the m = −1/2 and m = 1/2 sub-levels respectively. Then the excited atoms
decay back to the 23S1 with equal probability (label 3). The net result
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Figure 13: Representation of the helium electronic energy levels,
and the transitions involved in metastable optical pumping.
is a depletion of metastable atoms with low magnetic quantum numbers
(m = −3/2,−1/2) and an increase of metastable atoms with high magnetic
quantum numbers (m = 1/2, 3/2). In this way the helium metastable states
are polarised by the pumping light.
3He has an efficient coupling between its nucleus and its electrons
(known as the hyperfine interaction), meaning there is an entanglement
of electronic and nuclear spin states. Therefore optical pumping of the
electronic angular momentum simultaneously induces nuclear orientation as
well [6].
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Figure 14: Diagram of the 3He metastable exchange collision.
3He ground-state atoms are denoted He, metastable atoms are denoted He+, excited
metastable atoms are denoted He*, and the nuclei spin state is represented by the arrow.
The metastable electronic state and ground-level states are coupled
via metastability exchange collisions (label 4). Figure 14 shows a represen-
tation of the metastability exchange collision. The result of the hyperfine
interaction and the metastability exchange collisions in 3He atoms is that
the emerging ground-state atom has a polarised nucleus. It was found that
the metastability exchange collision dominates the ground-state 3He nuclear
magnetic relaxation rate (T1). This leads to the polarisation of the ground-
state 3He nuclei matching the degree of polarisation of the electronic spins
of the metastable atoms.
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4 MRI Pulse Sequences
4.1 Sequences for MRSolutions 0.15T Scanner
This section describes each sequence used on the 0.15T MRI scanner
during the studies, and how the data collected from them are analysed. All
of the sequences used in studies on the 0.15T MRI scanner were created to
measure the diffusion constant of the 3He gas, when inhaled by a volunteer,
at different time scales. There are sequences written for the 0.15 T scanner
that take images, but none were used in these studies, so will not be discussed
here.
4.1.1 CPMG Sequence
The Carr-Purcell-Meiboom-Gill (CPMG) sequence, initially developed
by Carr and Purcell, then added on to by Meiboom and Gill, is commonly
employed to enhance the Signal to Noise ratio of a NMR spectrum. As
seen in Fig.15, CPMG is a one-shot spin echo sequence, consisting of a non-
selective 90◦ RF pulse, followed by an echo train, induced by successive
non-selective 180◦ pulses. To suppress any effects of imperfections in the
180◦ pulses, the phase is switched by 180◦ for each successive 180◦ pulse.
For diffusion weighting, gradients are added between each pulse (during
acquisition), as shown in Figure 15.
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Figure 15: Diagram of the CPMG sequence.
The signal intensity of the echo measured at each successive acquisition
is attenuated by both diffusion of the target particles (denoted by D, the
diffusion constant), and by the ratio of the Echo Time, TE, and the T2 time,
according to:
Sn
S0
= e−n b D e
TE
T2 (24)
where Sn is the signal intensity of the n
th echo, while S0 is the signal intensity
if there was no attenuation. The b represents the ”b-value”, a term expressing
the amount of diffusion sensitivity applied by the gradients. The b-value is
expressed as:
b = γ2G2δ2(∆− δ
3
) (25)
where γ is the gyromagnetic ratio, G is the strength of the applied gradient
fields, δ is the length of the gradient lobe, and ∆ is the time between the
two lobes.
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In all studies, this sequence was implement with the same settings: 64
echoes, 64 sampling points at 30 µs sample period, a TE of 14 ms, a TR of
4000 ms, a δ of 1 ms, a ∆ of 13 ms, and a gradient strength of 2.23x10−5 T
cm−1 such that the gradients corresponding to a total b-value of 0.29 s cm2.
The T2 relaxation of
3He in the lung at 0.15T has been previously
measured [97], and found to be 5 seconds. This means that the loss of
signal due to diffusion is therefore much greater (by an order of magnitude)
than that of the loss due to T2 decay, such that the T2 term in equation 24
can be ignored. So the equation becomes:
Sn
S0
= e−n b ADC (26)
where D has been replaced by ADC, the Apparent Diffusion Constant. By
plotting the log of the normalised signal decay against acquisition number n,
where the gradient is equal to −bADC, the ADC of 3He in the subject’s lung
can be calculated. Fig.16 shows this analysis for 3 CPMG scans performed
on the same volunteer.
As there was a gradient on during the acquisition of each echo, the
data has been frequency encoded, meaning 1-dimensional information can
be recovered, and hence the ADC at each x-axis point can be calculated.
Fig. 17 shows an example of the 1D signal intensity profile gained from the
first echo of a CPMG scan.
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Figure 16: Analysis of 3 CPMG Scans Performed on an Asthmatic
Volunteer
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Figure 17: 1-Dimensional Profile of the Lungs
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The data from each echo are transformed in this way, and the signal
intensity decay at each point is used to calculate an ADC value (in the same
manner as for the global value discussed before). Fig. 18 shows an example
of the ADC profile this method produces.
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Figure 18: 1-Dimensional ADC Profile of the Lungs
From this, the ADC values are placed in a histogram, from which the
mean ADC value can be calculated. To remove the ADC values that are
not from the lungs, a second histogram is created which has the ADC values
”weighted” by the original signal intensity at that 1D voxel. Fig. 19 shows
a typical histogram produced from this technique.
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Figure 19: ADC Histogram, Showing Both Normal and Weighted
Histograms
It has already been reported [98] that ADC at short-time scales has
a strong positive correlation with the degree of lung inflation, such that a
volume-correction must be applied to the ADC values calculated. Using the
correction equation developed by Ball [4], we have that:
ADC = ADCv + 0.36 ∗ ADCv ∗ ( VBVFRC ) (27)
where ADCv is the ADC before volume-correction, VB is the volume of
the bolus of 3He/4He inhaled by the subject, and VFRC is the Functional
Residual Capacity (volume of air remaining in the lungs at the end of a
normal exhalation) volume of the subject. While performing this scan, the
subject inhales in the bolus at FRC.
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4.1.2 gADC Sequence
The global Apparent Diffusion Constant (gADC) sequence, as seen in
Fig. 20, is a simple gradient echo sequence, using a low flip-angle (α) non-
selective pulse, that is repeated 50 times. Out of the 50 acquisitions taken,
40 have diffusion weighting gradients applied, for the same duration, but
with varying strengths. The other ten have no gradients applied, though
still have the same TE time.
Figure 20: Diagram of the gADC sequence.
The 10 gradient free acquisitions occurred as every 5th acquisition, to
allow for correction against T1 decay and RF depletion. The signal attenu-
ation for the diffusion weighted acquisitions can be approximated as:
Sn = S0 e
−n TR
T1 e−bn ADC cosn(α) (28)
where Sn is the signal intensity for acquisition number n (starting at n=0),
S0 is the signal intensity of the n=0 acquisition, TR is the repetition time, α
is the flip angle of the RF pulse, ADC is the Apparent Diffusion Constant,
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and bn represents the ”b-value”, a term expressing the amount of diffusion
sensitivity applied by the gradients for the nth acquisition. The bn-value for
this sequence is expressed as:
bn = γ
2G2n
[
δ2
(
∆− δ
3
)
+ τ
(
δ2 − 2∆δ + ∆τ − 7
6
δτ + 8
15
τ 2
)]
(29)
(from [108]), where γ is the gyromagnetic ratio, G is the strength of the
applied gradient fields, δ is the length of the gradient lobe, and ∆ is the
time between the two lobes, and τ is the ramp time of the diffusion weighting
gradients. This equation differs from that of equation 25, as it contains an
extra term to correct for trapezoidal shaped gradients.
In the Leicester Royal Infirmary Cystic Fibrosis study, this sequence
was implemented with the following settings: 50 repetitions, 2048 sampling
points at 80 µs sample period, a TE of 11 ms, a TR of 200 ms, a δ of 4.4 ms,
excluding the ramp time of 150 µs on each side of the gradient, and a ∆ of
5.2 ms. The bn-value for each acquisition varies due to the different gradient
strengths, with a maximum value of b= ∼56 s cm2.
As the typical TR for this sequence was 200 ms, and the T1 was as-
sumed to be ∼25 s, so the T1 term can be ignored, simplifying equation 28
to:
Sn = S0 e
−b ADCcosn(α), (30)
and when the bn-value equals 0, i.e. for the 10 acquisitions that lack gradi-
ents, equation 28 simplifies to:
Sn = S0cos
nα. (31)
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If the line y = mcx−1 is fitted to the 10 ”calibration” acquisitions,
the equation S = S/c(x−1) can be used to correct the diffusion weighted
decay data, leaving only the attenuation due to diffusion. Fig. 21 shows the
diffusion decay of a typical scan, alongside the ’calibration’ decay, and the
best-fit line y = mcx−1.
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Figure 21: gADC Signal Decay Plot
Once corrected, the signal intensity is plotted against its corresponding
bn-value. To this the Yablonskiy Model [109] can be fitted, which returns
the parameters R (the radius of the alveoli duct) and h (the width of the
alveoli sac). Fig. 22 shows a typical b-space plot, along with a Yablonskiy
fitting.
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4.1.3 STE Sequence
The STimulated Echo (STE) sequence, as seen in Fig. 23, consists of
5 non-selective small flip angle (α) pulses and acquisitions (known as the
calibration stage). This is then followed by the set-up stage, consisting of a
non-selective 90◦ pulse, a diffusion weighting gradient, another non-selective
90◦ pulse, and then a crusher gradient. This is followed by the read out
stage, which consists of 45 non-selective α pulses followed by acquisitions
with refocus diffusion weighting gradients and then crusher gradients. This
sequence is similar to the global STE sequence described by Wang et al [94].
Figure 23: Diagram of the STE sequence.
The calibration stage is a simple pulse and FID acquisition, with the
flip angle of the pulse, and the repetition time TR, matching that of the
read out stage. The signal intensity of the calibration stage is attenuated
according to:
Sn = S0 sin(α) [ cos(α) e
−TR
T1 ]n−1 (32)
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where α is the flip angle of the RF pulse, Sn is the signal intensity of the
nth acquisition, and S0 is the original signal intensity if no attenuation was
present.
In all studies, this sequence was implement with the same settings: A
low flip angle α of 5◦, 1024 sampling points at 20 µs sample period, a δ
of 2.2 ms, and a gradient strength of 3.708x10−6 T cm−1. Each calibration
and read out section lasted 150ms each, with the time between the two pi/2
pulse as 12ms and the time between the last pi/2 pulse and the start of the
first read out section 18ms.
As the typical TR for this sequence was 150 ms, and the T1 is assumed
to be ∼25 s, meaning the T1 term can be ignored, such that equation 32
can be simplified to:
Sn = S0 sinα cos
n−1(α) (33)
The set-up block consists of two 90◦ pulses, between which is a sin-
gle diffusion weighting gradient. The read block consists of a small pulse
(matching that of the calibration stage), followed by an acquisition with a
diffusion sensitising gradient, during which an echo is formed. The signal
intensity of the echo formed in the read out block attenuates according to:
Sn =
1
2
S0 sin
2(90) sin(α)
[
cos(α) e
−TR
T1
]NC [ cos(α) e−TRT1 ]n−1 e−bn ADCn
(34)
where NC is the number of repetitions in the calibration stage, S0 is the orig-
inal signal intensity if no attenuation was present, Sn is the signal intensity
of the nth read out block acquisition, and ADCn is the Apparent Diffusion
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Constant for the nth acquisition, for the time-scale as measured between the
dephasing gradient following the first 90◦ rf pulse in the set-up stage and
the rephasing gradient of the nth read out acquisition. As for equation 32,
this can be simplified to:
Sn =
1
2
S0 sin
2(90) sin(α) cos(α)NC+n−1 e−bn ADCn (35)
So from fitting the equation y = m cos(c)x−1 to the calibration stage
FIDs, and then using the result to apply the equation
Sn =
2S0
sin2(90) m cosNc+n−1(c)
to the read out stage echoes, meaning that
all that is left is the attenuation due to diffusion at each acquisition point
(Sn = e
−bn ADCn). Fig. 24 shows the attenuation of the calibration FIDs,
and read out echoes, along with the fitted line and ”corrected” values.
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Figure 24: Signal Intensity of the STE Acquisitions Against Time
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From this the Apparent Diffusion Constant (ADC) at each read out
acquisition can be calculated using:
ADCn =
−ln(Sn)
bn
(36)
where bn represents the ’bn-value’, a term expressing the amount of diffusion
sensitivity applied by the gradients, depending on the gradient strength and
period. bn is expressed as:
b = γ2G2δ2
[(
∆n − δ3
)
+ τ
(
δ2 − 2∆nδ + ∆nτ − 76δτ + 815τ 2
)]
(37)
where γ is the gyromagnetic ratio, G is the strength of the applied gradient
fields, τ is the ramp time of the diffusion weighting gradients, δ is the length
of the diffusion sensitising gradient in the set up stage, and ∆n is the time
between the diffusion sensitising gradient in the set up stage and the diffusion
sensitising gradient in the nth read out acquisition.
This means that the ADC for various diffusion time lengths can be
recovered from a single scan. Fig. 25 shows a typical result from a single
scan on a volunteer.
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4.2 Sequences for GE 1.5T Scanner
This section describes each sequence used on the 1.5T GE MRI scanner
during this study. There are many GE certified proton sequences available on
the 1.5T scanner, but for use with 129Xe, broad-banded non-GE sequences
are required as well (known as ’site’ sequences). Both the GE proton se-
quences and the broad-banded 129Xe site sequences are discussed, with a
final discussion on the safety of the sequences.
4.2.1 GE Sequence: 3-Plane Localiser
The 3-Plane localiser is a GE certified clinical sequence by GE, pri-
marily used to locate the target for following scans, so that they can be
correctly positioned.
The 3-Plane localiser sequence is a TE optimised gradient echo se-
quence (as seen in Fig. 26) with a selective RF pulse (whose flip angle (α)
can be set per scan), that is repeated (at the same phase encoding step) for
each slice (in one direction) inside a single TR, before repeating as needed
for phase encoding. 5-6 slices are taken, in all 3 directions (Axial, Sagittal
and Coronal). When being used for co-registration for Xenon (meaning that
the RAPID coil is inside the scanner) a low SAR version is used, where the
TR time is increased, and the pulse flip angle reduced such that there is no
risk of damage to the RAPID coil.
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Figure 26: Diagram of the 3-Plane Localiser sequence.
The data can then be reconstructed into an image, by either the on-
board GE reconstruction engine, or elsewhere using the program ’RECON’
(see Section 4.3).
4.2.2 GE Sequence: T2 Prepared SSFSE
The T2 prepared SSFSE sequence is a certified clinical sequence by
GE. It consists of a single shot spin echo routine with selective pulses (the
initial α pulse flip angle can be set before each scan), executed at the fastest
speed (i.e. shortest Te) that the system can perform. To give T2 weighting,
a number of echoes are ignored at the beginning to simulate a long initial
Te time (known as Te effective).
By performing multiple scans, with varying Te effective times, the T2
of the sample can be calculated at each pixel. The signal intensity for scan
is described by:
Sn = S0e
−Te
T2 (38)
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Figure 27: Diagram of the T2 Prepared SSFSE sequence.
where Te is the effective Te for scan n, Sn is the Signal intensity for scan n,
S0 is the signal intensity for a scan with an effective Te of 0. However, this
does not account for noise. Adding a noise term (N), gives:
Sn =
√
(S0e
−Te
T2 )2 +N2 (39)
Using this equation, the T2 for each pixel of the scans can be calculated,
creating a T2 map, once the data have been reconstructed into 2D images.
This can be performed by using the program ’RECON’ (see Section 4.3).
4.2.3 GE Sequence: Inversion Recovery SSFSE
The inversion recovery SSFSE sequence is a certified clinical sequence
by GE. It consists of a single shot spin echo routine with selective pulses
(the α pulse flip angle can be set before each scan), executed at the fastest
speed (i.e. shortest Te) that the system can perform. To give T1 weighting,
an initial 180◦ pulse is used, followed by a delay Ti, before the standard T2
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prepared SSFSE is performed (where echoes are ignored at the beginning to
simulate a long initial Te time (known as Te effective)).
Figure 28: Diagram of the Inversion Recovery SSFSE sequence.
By performing multiple scans, with varying Ti times, the T1 of the
sample can be calculated at each pixel. The signal intensity for scan is
described by:
Sn = S0 − 2S0e−
Ti
T1 (40)
However, this does not account for noise. Adding a noise term gives:
Sn =
√
(S0 − 2S0e−
Ti
T1 )2 +N2 (41)
Using this equation, the T2 for each pixel of the scans can be calculated,
creating a T1 map, once the data have been reconstructed into 2D images.
This can be performed by using the program ’RECON’ (see Section 4.3).
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4.2.4 Site Sequence: bb2dfast
The bb2dfast sequence was created at the University of Sheffield, and
is a broad-banded version of the GE certified 2dfast sequence. The 2dfast
sequence is a gradient echo sequence using a selective RF pulse (whose flip
angle (α) can be set before each scan), that has been optimised to improve
acquisition time. Fig. 29 shows a single acquisition of the bb2dfast se-
quence. The gradients are mostly played out in a triangular shape (except
where required to be a plateau for slice selecting or frequency encoding).
The acquisitions are then repeated as many times as are needed for phase
encoding, and then the sequence is repeated as many times as needed to
acquire all slices and images. Sometimes the slices are interleaved, taking
one acquisition of each slice (at the same phase encode step) within a single
TR.
Figure 29: Diagram of the bb2dfast sequence.
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The data can then be reconstructed into an image, by either the on-
board GE reconstruction engine, or elsewhere using the program ’RECON’
(see Section 4.3).
4.2.5 Site Sequence: bbfgre
After the scanner console was updated from EPIC version 14M5 to
16, the existing site sequence, bb2dfast, could no longer be used. Instead a
new sequence was created, by broad-banding the GE certified fgre sequence.
Like the 2dfast sequence, the fgre is also a gradient echo sequence using a
selective RF pulse (whose flip angle (α) can be set before each scan), with a
few slight differences, mainly in the setup options. The bbfgre sequence was
created in house at the University of Nottingham. Fig. 30 shows a single
acquisition of the bbfgre sequence. As with the bb2dfast, the gradients
are mostly played out in a triangular shape (except where required to be
a plateau for slice selecting or frequency encoding). The acquisitions are
then repeated as many times as are needed for phase encoding, and then
the sequence is repeated as many times as needed to acquire all slices and
images. Sometimes the slices are interleaved, taking one acquisition of each
slice (at the same phase encode step) within a single TR.
One of the prime reasons for broad-banding the fgre sequence over the
2dfast sequence was the larger amount of setup options available. One such
setup options is the phase-encoding method, which was permanently set to
sequential only on the 2dfast sequence, where-as the fgre provides multi-
ple options, such as centre-out. Another setup option of interest was the
minimum frequency/phase resolution, which with the 2dfast was 128x128,
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Figure 30: Diagram of the bbfgre sequence.
whereas the fgre sequence allowed resolutions down to 64x64.
As with bb2dfast, the data can then be reconstructed into an image,
by either the onboard GE reconstruction engine, or elsewhere using the
program ’RECON’ (see Section 4.3).
4.2.6 Safety - Site Sequence Code Review
To ensure that the Site sequences are safe for use on human volunteers
(along with the non-GE 129Xe RAPID Coil) the sequences must be checked,
and SAR levels measured experimentally.
In EPIC programming, SAR estimations are performed by converting
the RF pulses into an equivalent number of ’standard’ RF pulses, and then
entering them into the following equation:
Average SAR =
(
No. of ′standard′RF
pulses in sequence
)
×
(
Energy deposited by
′standard′RF pulse
)
(Sequence repetition time) × (Patientweight)
(42)
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The estimated energy deposited by a standard pulse into a patient
is a function of patient’s weight, strength of the B0 field, and the coil
used. GE have determined this experimentally, by scanning patients of
various weights and sizes, at different field strengths. These estimates have
then been stored in the code file ’peakrf.c’ It uses just one set of equa-
tions for both PSD BODY (the opcoil value of the main BODY coil), and
PSD SURFACE (the opcoil value of the 129Xe RAPID Coil). This is where
an error in the SAR calculations can arise, as the SAR equation will not take
into account the characteristics (such as close proximity) of the coil.
To convert a single RF pulse into Standard Pulses, the peak B1 of the
RF pulse, as it is played out in the sequence, is calculated using the following
equation:
peak B1 = max b1 × nom pw
pw
× act fa
nom fa
, (43)
where nom pw is the nominal pulse width (the time the pulse is played out
for, which may or may not be the same as the actual pulse width of the
pulse), nom fa is the nominal flip angle (the flip angle the pulse delivers if
its actual pulse wdith was nom pw and its peak B1 was at the maximum),
max b1 is the peak pulse amplitude (if the RF pulse width was nom pw and
the desired flip angle was nom fa). pw is the actual pulse width as played
out in the sequence, and act fa is the actual flip angle of the pulse as it is
implemented.
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Now that the peak B1 has been calculated, the number of Standard
Pulses per sequence can be calculated using:
#Std. Pulses = num × effwidth × pw
std.pulse′swidth
× peak B1
std. pulse′sB1
.
(44)
where num is the number of times the actual pulse is used in the sequence,
and effwidth is the effective pulse width (an integral of the pulse amplitude
squared, divided by the width of the pulse, mad on normalized pulses).
effwidth is used to compare energies of RF pulses of differing shape.
Although the SAR calculation in itself is not too complex, it is impor-
tant that the sequence code implement pulses consistently with the param-
eters that are used in the SAR calculations. If one is modifying a product
sequence code, it is important that the arguments to the powermon b1scale()
function are correct, as within this internal function is where the SAR cal-
culations are performed, and that fields in the rfpulse structure are filled
in correctly for any new RF pulses either in the sequence code or in the
’grad rf <psdname>.h file’. Thus, in modifying a product sequence code,
it is not hard to ensure that the SAR calculations are correct.
This was confirmed by a review of both the bb2dfast and bbfgre code,
where it was found that the powermon b1scale routine inputs were still as
they were in the original GE source code they were based on, and that all the
important variables that the SAR calculations used were still initialised and
used correctly. To further review the sequences, an oscilloscope was attached
to the X, Y and Z gradient outputs, as well as the RF pulse output. Then
each sequence was played out, using a variety of settings, monitoring the
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results on the oscilloscope each time. It was found that for every setting
used the gradients and RF pulses played out as expected, occurring at the
correct time and for the correct length and power, for both Proton and
Xenon modes. This strongly implies that the source codes were implemented
correctly.
4.2.7 Safety - SAR Experiments
After reviewing the sequences, the max SAR of the sequence, when
used with the 129Xe RAPID Coil, must be checked experimentally.
The specific absorption rate (SAR) can be measured physically by
monitoring the temperature change of a phantom subjected to the sequence
over time. The equation for calculating the SAR (in Wkg−1) is:
SAR =
C ×∆T
t
, (45)
where C is the specific heat capacity of the phantom (JK−1kg−1), ∆T is
the measured change in temperature (K), and t is the exposure time (s).
For the SAR tests, 1 L Saline bags were used as the target phantom/s,
which consisted of 0.9% Sodium Chloride by volume. At this low concen-
tration of Sodium Chloride, the specific heat capacity can be assumed to
be the same as that for pure water (4181 JK−1kg−1). SAR tests were run
using the BODY coil with a GE standard Fast Spin Echo sequence (called
FSE-XL on the scanner) for a proof of concept test, and then at both Xenon
and Proton frequencies for the bb2dfast sequence and at Xenon frequencies
only for the bbfgre sequence, using the BODY coil for the Proton frequency
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runs and the RAPID coil for the Xenon frequency runs. For the BODY coil
tests one or two phantoms were used, positioned on the center of the bed.
For the bb2dfast/bbfgre Xenon frequency tests the RAPID coil was filled
with 20 bags, so that the minimum loading of 20 kg required by the coil was
achieved. During each test run, the before and after temperature of one or
more bags were measured. Control bag/s were also measured alongside the
test bag/s, and left on the bed just outside the scanner bore during scanning.
This was done to ensure that any temperature change measured in the test
bag/s subjected to the scan were not due to temperature fluctuations in the
room.
The temperature measurements were performed immediately before
and after the scans, using a Quartz Digi-Thermo thermometer. For each
measurement the probe of the thermometer was inserted into the Saline
bags through a valve, and left for a minute for the temperature reading to
stabilise, before being removed and the valve resealed. The Digi-Thermo
thermometer resolution is 0.1◦C. The value used in SAR calculations is the
change in temperature of the test bag (∆TP ), minus the change in temper-
ature of the control bag (∆TC).
As can be seen in the results table (Table 3), the Proton frequency
tests showed a measurable but small increase of temperature over the con-
trol phantom, and the calculated SAR value is similar to that which was
estimated by the scanner for the sequence. For the protocols of the scans
used, see A.1. The temperature increase for the first few bb2dfast scans
matches those of equivalent FSE-XL sequences with the same Est. SAR
value, however the latter bb2dfast scans see a greater temperature increase.
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These scans were performed later in the day, after long periods of MRI use.
It may be that constant use of the MRI scanner lead to a slight warming of
the bore of the MRI scanner compared to the rest of the room.
Table 3: Proton Test Results
Sequence Protocol ∆TP ∆TC t (s) Calc. Est.
(K) (K) SAR (W kg−1) SAR (W kg−1)
FSE-XL 2 0.7 0.0 2570 1.14 1.4
FSE-XL 1 0.5 -0.1 2980 0.84 0.9
FSE-XL 3 0.8 0.1 2567 1.14 1.7
FSE-XL 3 0.9 0.0 2567 1.47 1.7
FSE-XL 3 0.8 0.0 2567 1.30 1.7
bb2dfast 4 0.8 -0.2 2595 1.61 1.7
bb2dfast 4 0.8 -0.2 2595 1.61 1.7
bb2dfast 4 1.7 -0.2 2595 3.06 1.7
bb2dfast 4 1.9 -0.2 2595 3.38 1.7
bb2dfast 6 1.6 -0.1 2595 2.74 1.7
bb2dfast 6 1.3 -0.1 2595 2.26 1.7
For the Xenon frequency tests on bb2dfast and bbfgre, multiple posi-
tions inside the RAPID coil were tested, to check for localised heating effects.
Fig. 31 shows the positions of the phantoms measured. For the protocols of
the scans used, see A.2. As the only concern is the emitted RF, the upper
receive coil was not used during the scans to allow closer access to the upper
transmit coil.
When running the bb2dfast and bbfgre sequences, it was apparent
that when the target nuclei was changed from 1H to 129Xe, the Estimated
SAR reduced by a factor of ∼16, which is similar to the expected change,
as the RF frequency required for 129Xe is 4 times lower than that needed for
proton, and as RF power has a square relationship to frequency, this would
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Figure 31: Positions of the Phantoms Measured.
Positions of phantoms (1-7) inside RAPID Coil, with the control (C) on the bed outside the scanner.
(a) Axial Cross-Section View. (b) Top Down View.
mean about 16 times less RF power for 129Xe than for proton. However
it should be noted that the SAR calculations do not change when swapped
from BODY to RAPID coil, as it does not have the knowledge of the specifics
of the RAPID coil.
As can be seen in the results table (Table 4), there was a measurable
increase of temperature in some of the bags. Mostly the temperature in-
crease is negligible, or is likely due to slightly more RF intense local zones.
Most of the higher temperature increases ( 0.5-0.7◦C) were seen in tests that
had been performed later in the day, after many previous tests. It was no-
ticed that after such long use the outer shell of the RAPID coil was slightly
warm to the touch. Hence some of the heating may be accredited to the
heating of the internal circuitry of the RAPID emit coil as opposed to being
purely due to absorption of the emitted RF. However the coil was not ex-
cessively warm, so contact burns were not considered a risk. However, the
temperature increases involved never reached those of the High SAR level
Proton scans. This implies that the bb2dfast/bbfgre sequences and RAPID
coil are safe to use on patients, especially when it is remembered that to get
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these temperatures the scan ran for over 40 minutes with a high flip angle of
45◦, whereas on a human subject it will be ran for no more than 20 seconds
(a breath hold), and often with a much lower flip angle.
Table 4: bb2dfast/bbfgre Xenon Test Results
Sequence Position Protocol ∆TP ∆TC t (s) Calc. Est.
(K) (K) SAR SAR
(W kg−1) (W kg−1)
bb2dfast 2 1 0.0 -0.1 2411 0.17 0.0
bb2dfast 1 1 0.4 0.1 2411 0.52 0.0
bb2dfast 3 1 0.3 -0.1 2411 0.69 0.0
bb2dfast 5 1 0.5 0.5 2411 0.00 0.0
bb2dfast 6 1 0.5 0.0 2411 0.87 0.0
bb2dfast 7 1 0.3 0.0 2411 0.52 0.0
bb2dfast 2 1 -0.1 0.0 2411 -0.17 0.0
bb2dfast 1 1 0.0 0.0 2411 0.00 0.0
bb2dfast 3 1 0.1 0.0 2411 0.17 0.0
bb2dfast 4 1 0.0 -0.1 2411 0.17 0.0
bb2dfast 6 1 0.1 -0.1 2411 0.35 0.0
bb2dfast 7 1 0.3 -0.1 2411 0.69 0.0
bb2dfast 2 2 0.5 -0.1 2411 1.04 0.1
bb2dfast 1 2 0.7 -0.1 2411 1.39 0.1
bb2dfast 3 2 0.7 -0.1 2411 1.39 0.1
bb2dfast 4 2 0.6 0.0 2411 1.04 0.1
bb2dfast 6 2 0.6 0.0 2411 1.04 0.1
bb2dfast 7 2 0.3 0.0 2411 0.52 0.1
bbfgre 1 3 0.2 -1.5 2940 0.57 0.0
bbfgre 2 3 0.1 -1.5 2940 0.43 0.0
bbfgre 3 3 0.2 -1.5 2940 0.57 0.0
bbfgre 4 3 0.2 -1.5 2940 0.57 0.0
bbfgre 5 3 0.1 -1.5 2760 0.45 0.0
bbfgre 6 3 0.0 -1.5 2760 0.30 0.0
bbfgre 7 3 0.2 -1.5 2760 0.61 0.0
bbfgre 4 4 0.0 0.0 1440 0.00 0.0
bbfgre 2 4 0.0 0.0 1440 0.00 0.0
bbfgre 6 4 0.2 0.0 1440 0.58 0.0
bbfgre 7 4 0.0 0.0 1440 0.00 0.0
76
4.2.8 Safety - Conclusion
The review of the codes, along with the knowledge of how EPIC se-
quence codes perform their safety checks, shows that both codes appear to
perform the SAR calculations correctly, except for an estimation of the spe-
cific coil used. This discrepancy is the most likely cause of any difference
between the estimated SAR and that measured in the SAR tests. This dis-
crepancy must be kept in mind when using this sequence with any non-GE
coil.
The SAR tests show that there is a higher than estimated heating
effect when using the 129Xe coil, but that it is still well below safe limits
even with RF rich versions of the both Site sequences. If other sequences
are to be used on this coil, it is highly recommended that SAR tests are
performed to confirm their actual max SAR, as was done with bb2dfast and
bbfgre, before use on human volunteers.
In conclusion the sequences bb2dfast and bbfgre were deemed safe for
use on human volunteers with all GE coils, and the 129Xe RAPID Coil.
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4.3 Image Reconstruction
Both the 0.15T and 1.5T MRI systems have an array of imaging se-
quences, which may be used during test runs and studies. Although they
both have in-built image reconstruction, there is little to no control on how
the final image looks, and much of the raw data is lost as the image can
only be saved in traditional image formats (.JPG, DICOM). Hence it is im-
portant that the raw data files from both platforms can be read, interpreted
and reconstructed elsewhere, with greater user control and keeping all data
intact for any further analysis that may be desired.
In response to this need, the multi-platform Graphical User Interface
program called ’RECON’ was created, alongside a secondary command-line
based streamlined version called ’RECONlite’. Both programs provide im-
age reconstruction from raw data files produced by either MRI scanner, with
options to save the raw data, reconstructed data, and header information in
ASCII text file format, as well as saving the reconstructed image in tradi-
tional image formats (.PNG,.BMP). On top of this, ’RECON’ has a plethora
of extra features, such as white balance, 3D modeller, multi-file reconstruc-
tion, T1 and T2 map analysis, ADC map analysis and image masking anal-
ysis. The following is a brief review of the features of the programs, and
how they work.
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4.3.1 Raw Data File Interpretation
The single most important part of both programs is to be able to
interpret both MRI scanners raw data files. Both the raw image data and
any header/footer information containing scan details must be recovered, as
both are required for full reconstruction and analysis.
For the 0.15T MRSolutions console, the raw data is saved to a ’.MRD’
file. As can be seen in Table 5, the file is split into 3 main sections: Header,
Data and Footer. The header section contains the main key values, required
to interpret the data section, such as x/y/z/d/e dimensions, and the data
type (short/long int, float, double, complex, etc.). The data section contains
the actually raw data from the scan, in ’datatype’ format, ordered by x, y,
z, d then e blocks. Immediately following the data section is the footer.
The footer contains all the settings used in the scan sequence, in ASCII char
format. It can be variable in length, as the number of user-editable variables
in a sequence can vary. Each variable in the footer starts with a ’:’, followed
by the variable name (e.g. ’PPL’), then a space, then 1 or more values
separated by ’, ’ (e.g. ’C:\SEQUENCES\FGRE.PPL’). If the variable name
is ’VAR’, it represents a non-standard variable, and the first value following
it is the name given to it in the source code (e.g. ’:VAR read lobe, 100’).
The raw data on the 1.5T GE scanner is saved into as a binary ’P-
file’, which has the file name P#####.7, where the ##### is a 5 digit
number representing the run number of the scan. Sometimes longer scans
of multiple phases or slices are split into multiple P-files, with incrementing
numbers. Table 6 shows the structure of a P-file. It consists of two main
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Table 5: Structure of a .MRD raw data file
Section Data Name Data Type Size (bytes)
X size long int 4
Y size long int 4
Z size long int 4
D size long int 4
padding short int 2
datatype short int 2
Header padding long int x7 28
512 bytes scaling float 4
padding long int x14 56
bitsperpixel char 1
padding char x3 3
padding long int x10 40
E size long int 4
padding long int x25 100
text char x256 256
Data Image data Dependant on Xsize x Ysize x Zsize
? bytes ’datatype’ x Dsize x Esize x ’datatype’
Footer Footer data char x? Variable
?
80
sections, the header and the data. The header in a P-file contains a lot more
information than the .MRD files, a reflection on the vastly more complicated
sequence source codes used by the GE system. The header section is split
into 11 sub-sections, each containing information on different settings used
in the scan. Immediately following the header section is the image Data. It
can be correctly interpreted according to values given in the header sections
(such as x-resolution, y-resolution, data-type, etc.)
Table 6: Structure of a P#####.7 raw data file (version 14.3)
Section Sub Section Description Start byte Size (bytes)
rdb hdr Database Header 0 2048
perpass hdr Per Pass Header 2048 16384
uraw hdr Unlock Raw Header 18432 16384
data hdr Data Header 34816 98304
nex hdr NEX Header 133120 2052
Header nexabort hdr Nex Abort Header 135172 2052
tool hdr Tool Header 137224 2048
ps hdr PS Header 139272 1500
exam hdr Exam Header 140772 1040
series hdr Series Header 141812 2048
image hdr Image Header 143860 2048
Data Image Data Image Data 145908 ?
4.3.2 Image Scaling and Gaussian Filter
Once the files have been interpreted, the image data can then be
reconstructed into an image. Basic image reconstruction consists of a 2-
Dimensional Fast Fourier Transform (2DFFT) applied to each set of image
data. This creates an image of equal size to that of the original data (i.e.
a 128 x 128 data set creates a 128 x 128 image). However these images are
often small, typically 128x128. To get a larger image for easy viewing, they
should be increased to 512x512. The best way to perform this, with the least
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distortion effects (such as pixelation), is to create a 512x512 zero-filled array,
and place the original data in the centre of it, before performing the 2DFFT.
This results in a respectable looking larger image. Figure 32 shows an ex-
ample of this technique, compared to resizing the image post-reconstruction
(using GNU Image Manipulation Program, (GIMP)).
Figure 32: Pre and Post 2DFFT Image Scaling
Original data 128x128. Scaled to 512x512
(a) Original Image.
(b) Scaled using GIMP Post-2DFFT. (c) Padded with zeros Pre-2DFFT.
Often there is false detail created from this scaling process. This can
be removed, with the image brightened at the same time, by applying a
Gaussian Filter prior to the 2DFFT. A Gaussian filter scales the value at
each data point according to a Gaussian peak centred on the middle of the
array. So in a 1-dimensional array of length Lx, the data D at point x would
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be scaled by:
D = D ∗ e−(x−Lx/2)2/2(σLx)2 , (46)
where σ is the standard deviation of the Gaussian filter (normalised to the
length of the array). For a 2D array, the 1-Dimensional filter is simply
applied once for each data-point in the x-direction, then again across each
data-point in the y-direction. Figure 33 shows the result of applying the
Gaussian filter with different σ values.
Figure 33: Gaussian Filter Examples
(a) No Gaussian Filter applied. (b) Gaussian Filter applied, σ = 0.1.
(c) Gaussian Filter applied, σ = 0.05. (d) Gaussian Filter applied, σ = 0.01.
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4.3.3 Partial k-Space Reconstruction
When a fast scan sequence is required, it is sometimes necessary to
perform a partial NEX scan (i.e. do less than the full amount of acquisitions),
and/or a partial Echo (take less samples per acquisition) to reduce the TR,
TE or total scan time. In both cases, the simplest way to reconstruct is to pad
the missing data with zeros before performing the 2DFFT. For partial Echo
images the zero-padded reconstruction looks fine, but for partial NEX the
reconstructed image is significantly blurred in the phase-encode direction.
To fix the blurring, the missing (uncollected) data must be filled in.
This is achieved via a simplistic version of the POCS (Projection Onto Con-
vex Sets) algorithm [40]. Figure 34 shows the steps involved in the POCS al-
gorithm. The original k-space data is padded with zeros, while a second data
set is created, using only the central symmetric k-space data and padded
with zeros. Both are then 2DFFT into images Mi and Ms respectively. Then
the phase-corrected image P is created via the following formulas:
Mie(x, y) = eiarg(Mi(x,y)), (47)
P (x, y) = Mie(x, y)abs(Ms(x, y). (48)
A inverse 2DFFT is then performed on Image P to return it to k-
space data, which is then used to replace the zero-padding section in the
original k-space data. A 2DFFT is applied once more to create image Mi,
and then the process is repeated multiple times, finally ending when image P
is satisfactory. Figure 35 shows an example image with no POCS algorithm
correction and various numbers of POCS algorithm iterations. There is a
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Figure 34: Summary of the Simplified POCS Algorithm.
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clear reduction in blur between the no POCS and 1 iteration POCS images,
and a marginal reduction between 1 and 5 iterations. Performing 10 itera-
tions did not noticeably improve the image when compared to 5 iterations,
so 5 iterations of the simplified POCS algorithm has been implemented in
both RECON and RECONlite’s partial NEX reconstruction.
Figure 35: Partial NEX Reconstruction.
A 256x256 image taken with only 134 phase-encode steps (NEX=0.52).
(a) Simple zero-padding reconstruction. (b) POCS reconstruction, 1 iteration.
(c) POCS reconstruction, 5 iterations. (d) POCS reconstruction, 10 iteration.
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4.3.4 Gradient Warping
Inhomogeneous gradient fields can cause distortions in the images col-
lected, known as ’Gradient Warping’. Although the gradients are manually
corrected as much as possible when first installed, some inhomogeneity al-
ways remains, providing slight distortions to the acquired images. On the
lower field 0.15T this effect is greatly reduced and is barely noticeable, how-
ever on the 1.5T scanner it can cause visible deformities, such as straight
sections in the phantom being scanned appearing as curves in the acquired
image.
If the inhomogeneity of the gradient fields is known, this deformation
can be corrected in the final image. In fact, GE’s onboard reconstruction
engine does correct for the inhomogeneities in the 1.5T scanner’s gradient
fields. Hence it is important that RECON and RECONlite replicate this
reconstruction, such that important clinical images appear as they should.
The GE 1.5T scanner contains a file, called ’gw coils.dat’, that con-
tains the information describing the inhomogeneity of the scanner’s gradient
fields (as measured when first installed), via several spherical harmonic coef-
ficients. Using spherical harmonic equations, with the provided coefficients,
the gradient warping can be corrected. RECON and RECONlite use the
following equations for correcting the gradient warping, based on an inter-
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pretation of GE’s gradient unwarping process [2]:
Fx = x+ (c1x), (49)
Gx = c2x
(
(4z2)− x2 − y2
)
, (50)
Hx = c3x
(
(8z4)− (12y2z2)− (12z2z2) + y4 + (2x2y2) + x4
)
, (51)
Dx = Fx +Gx +Hx − x, (52)
where x,y and z are the x,y and z coordinates in real space of a pixel in the
uncorrected image, Dx is the offset to apply to x to get the true x-coordinate
of the pixel, and c1, c2 and c3 are the spherical harmonic coefficients (label
as ’SCALEX1’, ’SCALEX3’ and ’SCALEX5’ in ’gw coil.dat’ respectively).
To get the offset to the true y coordinates, the same equations are used,
swapping the x and y terms, and using the respective spherical harmonic
coefficients (c1 = SCALEY1, c2 = SCALEY3 and c3 = SCALEY5). To get
the offset to the true z coordinates, the following equations are used:
Fz = z + (c1z), (53)
Gz = c2z
(
(2z2)− (3y2)− (3x2)
)
, (54)
Hz = c3z
(
(8z4)− (40y2z2)− (40x2z2) + (15y4) + (30x2y2) + (15x4)
)
,
(55)
Dz = Fz +Gz +Hz − z, (56)
where the respective spherical harmonic coefficients are used (c1, c2, c3 =
SCALEZ1, SCALEZ3, SCALEZ5 respectively).
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Figure 36 shows an overview of the gradient unwarping process used
in RECON and RECONlite. A Catmull-Rom spline interpolation [5] is
utilised to create the new unwarped image, and the brightness corrected via
a Jacobian matrix (as compressed areas become brighter and stretched areas
become duller during the interpolation). Figure 37 shows an example of an
image before and after gradient unwarping using RECON.
Figure 36: Summary of the Gradient Unwarping Process.
4.3.5 RECON Bonus Functions
Alongside the image reconstruction as discussed in the previous sec-
tions, the GUI program RECON has additional features over the simplified
command-line program RECONlite, which only reconstructs the image and
optionally stores the raw/processed data and header information in ASCII
format for any further analysis elsewhere. Using RECON, the user can ad-
just the white balance of the images, load and reconstruct multiple files, see
important scan information at a glance, and perform a small selection of
further analysis.
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Figure 37: Example of Gradient Warping and Correction.
(a) Before Gradient Unwarping (b) After Gradient Unwarping
Figure 38 shows a reconstructed image, along with the some of the
important scan information displayed in RECON. Figure 39 shows RECON’s
file selection window, where multiple scan files can be selected. Figure 40
shows how RECON can be used to alter the white balance of a reconstructed
image.
For further analysis, RECON provides a mask analysis mode, where
areas of each image can be selected, and certain statistics for the selected
areas are displayed, such as the size of the selected area/s , and each areas
signal/area ratio. Figure 41 shows an example of the mask analysis in action,
comparing the signal/area ratio between the background noise, a lung, a
liver, and heart muscle.
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Figure 38: Scan Information and Reconstuction using RECON
(a) Reconstructed image, with patient information displayed.
(b) Reconstructed image, with scan information displayed.
91
Figure 39: Selecting Files in RECON
RECON can also be used to construct T1 and T2 maps, if multiple
scans with varying Te or Ti times are reconstructed. The images are formed
by fitting equations 39 or 41 via a least-squares algorithm to the pixels
of reconstructed images, and displaying the results as a heat map. Mean
T1/T2 values, both general and intensity weighted (from chosen scan), are
displayed, and area specific mean values can be displayed using the same
mask analysis program as described above. RECON can handle multiple
slices/phases, but all scans must contain the same number of slices/phases.
Figure 42 shows the background noise selection process required before run-
ning the map analysis. Figure 43 shows the a T2 map, and an example of
extracting area specific information using the mask analysis function.
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Figure 40: Image White Balance Alteration using RECON
(a) Default white balance.
(b) Altered white balance.
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Figure 41: Example of Mask Analysis in RECON
(a) Image before mask analysis is applied.
(b) Image with mask analysis is applied, where Mask 1 = Noise (green), Mask 2 = Liver (dark
blue), Mask 3 = Lungs (light blue) and Mask 4 = Heart (pink).
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Figure 42: RECON Noise selection using Masks
RECON also contains a 3D image reconstruction, which takes the
images from multiple slices, and gives them thickness (according to their
slice thickness) and assembles a 3D image that can be rotated as desired by
the user. Figure 44 shows an example of the 3D image reconstruction.
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Figure 43: Example of T2 Maps in RECON
(a) Example T2 Map.
(b) Example T2 map with mask analysis.
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Figure 44: RECON 3D Image Reconstruction
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5 Chiesi Study
5.1 Background
In 2010 an estimated 300 million people across the world suffered from
asthma, with the number likely to increase considerably in the following
decades [11]. It is known that asthma is a chronic inflammatory airway dis-
ease which affects both the large and the small airways, and is characterised
by airway hyper responsiveness, variable airflow obstruction and structural
remodelling [12]. However it is not known whether the inflammatory and
structural changes in asthma also occur in the distal acinar airways.
It is crucial to understand the effect asthma has on the acinar air-
ways, as currently available inhaled therapies do not penetrate to these air-
ways [16]. There has already been increasing interest in targeting the small
airways with inhaled therapies [85]. The structure of the acinar airways can
be non-invasively probed using a number of methods, such as the physio-
logical assessment of gas mixing using Multiple Breath inert gas Washout
(MBW) [74], Computed Tomography (CT) densitometry to evaluate expira-
tory air trapping [92], and measurement of gas diffusion using hyperpolarised
noble gas MRI [108]. No comprehensive assessment of the acinar airways
in asthma has been performed to date, that combines the use of all the
described methods.
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The gas mixing inefficiency in the lungs is thought to be due to two in-
dependent mechanisms: convection-dependent inhomogeneity (CDI), which
is due to unequal convective ventilation between small conductive airways
and the relatively large lung units; and diffusion-convection-dependent inho-
mogeneity (DCDI), a complex mechanism that arises due to an interaction
between diffusive and convective gas flows occurring at the region of the air-
way tree where these flows are approximately equal in magnitude. Verbanck
et al. [86] proposed two MBW parameters, Scond and Sacin, as measure of
CDI and DCDI (respectively). The convection-diffusion front, the region
of the airway tree where convection and diffusion gas flows occur with ap-
proximately equal magnitude (and the proposed site of DCDI), is thought
to be located within the pulmonary acinus. Due to this, Sacin was proposed
as a putative physiological marker of acinar airspace disease. However, the
molar mass of the probing gas can vastly alter the actual location of the
convection-diffusion front, with lighter gases (such as N2) probing earlier
in the airway tree than heavier gases (such as SF6) which can probe much
more distal regions of the pulmonary acinus [74]. Patients with asthma have
been observed to have elevated Sacin values [91], suggesting that a specific
structural abnormality in the pulmonary acinus may be a characteristic of
asthma, although its precise nature has not been made clear.
Using hyperpolarised 3He diffusion MR, the Apparent Diffusion Coef-
ficient (ADC) of 3He within the pulmonary acinus may be measured, across
a range of time-scales. The shorter time-scales, on the order of a few mil-
liseconds, correspond to diffusion inside a single alveolus or acinar airway,
with the longer time-scales, of the order of seconds, corresponding to dif-
99
fusion across several acinar airways [108]. There have been several stud-
ies that the short time-scale ADC of 3He or 129Xe is elevated in patients
with emphysema [32, 50, 75, 76, 93, 105, 107], and in animal models of em-
physema [10, 15, 56, 70] when compared to healthy lungs. Additionally, the
ADC was found to correlate with quantitative histological measures of em-
physema in a number of the studies, such as mean linear intercept, mean
alveolar internal area and mean chord length [10,15,56,70,93,105].
Physiological measurements of lung volumes [21], and quantitative CT
densitometry [92] can be used to assess air trapping in the lungs. CT imaging
phenotypes of asthma have recently been identified using such techniques,
and air trapping has been identified as a feature of all CT imaging clusters
associated with more severe disease [39].
This study was funded by the National Institute for Health Research
(NIHR) and partly funded through research collaborations with Chiesi Far-
maceutici S. P. A. and Novartis Pharmaceuticals. Additional funding was
received from the FP7 EU Airway Disease PRedicting Outcomes through
Patient Specific Computational Modelling (AirPROM) project.
5.2 Objectives
The aim of this study was to determine the nature of the acinar airway
involvement in patients with asthma. This was done using quantitative Com-
puted Tomography (CT) densitometry and 3He diffusion magnetic resonance
(3He-MR) at multiple time-scales alongside spirometry, body plethysmogra-
phy, and SF6 Multiple Breath Washout (MBW). It was hypothesised that:
100
1) Asthma patients with elevated Sacin would manifest altered long range dif-
fusion, suggesting intra-acinar airway disease; 2) Lung hyperinflation would
not affect the degree of acinar involvement in asthma.
5.3 Method
This was a collaborative study, with contributions from the following
people:
• Dr. Salman Saddique - Designed the study. Co-Principal Investigator.
• Prof. John Owers-Bradley - Helped design the study. Co-Principal
Investigator. Assisted in performance of MRI scans.
• Dr. Sherif Gonem - Performed clinical lung function tests at Glenfield
Hospital. Recruited and screened patients and volunteers. Performed
statistical analysis. Prime author on paper.
• Dr. Niels Buhl - Provided theoretical input for formulation of the STE
sequence and its analysis.
• Steven Hardy - Prepared 3He polarised gas and performed MRI scans.
Performed MRI raw data analysis. Created STE sequence. Performed
statistical analysis of results.
Wang et al [93] reported a 0.0051cm2s−1 difference in mean ADC at
1.5 s between the healthy and asthma groups, with a standard deviation of
0.0026cm2s−1 in the healthy group and 0.0055 cm2s−1 in the asthma group,
using a similar methodology to that used in this study. From this it was
calculated that to detect the same difference between healthy and asthma
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groups at 90% power, using a t test at 5% significance level, each group
required at least 15 participants.
37 asthmatic and 17 age-matched healthy subjects were recruited. The
participants were recruited from the secondary care asthma centre at Glen-
field Hospital, Leicester. The recruited population was representative of the
secondary care asthma population in the UK, and included patients with
treatment refractory disease. All participants were either never smokers, or
ex-smokers with less than 10 pack years smoking history. The diagnosis of
asthma in a secondary care setting was performed according to British Tho-
racic Society guidelines [79]. All participants gave their written informed
consent, and the study was approved with alterations by the National Re-
search and Ethics Committee (East Midlands, Leicester, Project code: ’UHL
09580’ , REC: ’04/Q2501/114’).
Patients, in the stable state with no changes having been made to
their regular inhaled or oral asthma therapy in the preceding six weeks,
first visited Glenfield Hospital, before being transported to the University
of Nottingham. At Glenfield Hospital, the participants underwent:
• Asthma Control Questionnaire [48]. (Asthmatic participants only)
• Asthma Quality of Life Questionnaire [47]. (Asthmatic participants
only)
• 200 micrograms of salbutamol, via a metered-dose inhaler and spacer.
• Spirometry, according to [61].
• Body Plethysmography, according to [96].
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• Measurement of Carbon Monoxide diffusing capacity, according to [55].
• Induced sputum inflammatory cell counts, according to [69].
• Multiple breath washout (MBW) according to [73], using sulphur hex-
afluoride and the technique detailed in [44].
The salbutamol was administered so that the confounding effects of
airway smooth muscle tone on physiological and imaging assessments were
minimised. The Global Lung Function Initiative (2012) [72] equations were
used to derive predicted values and standardised residuals (z scores) for
spirometry, and the European Community for Steel and Coal (1993) [71]
equations were used to derive predicted values and standardised residuals (z
scores) for lung volumes and the carbon monoxide transfer coefficient.
The choice of SF6 as the inert tracer gas was due to its heavy molar
mass, which means that it will probe the more distal regions of the pul-
monary acinus. A lighter gas such as N2 would not probe such regions [74].
Additionally, simulation data [26] suggests that phase III slope sensitivity to
SF6 is maximal at alveolar duct level (generations 20-21). A nose clip was
worn by the participants, as they breathed an air mixture containing 0.2%
SF6. Exhaled breath SF6 concentrations and respiratory flow were moni-
tored by an Innocor photo-acoustic gas analyser (Innovision A/S, Odense,
Denmark). A steady respiratory rate of approximately 12 breaths per minute
was maintained by the participants, along with a constant tidal volume of
1 L throughout the test. A real-time visual display of inspired volume was
used as a guide to allow the participant to achieve this. At the end of
the wash-in phase corresponding to equalisation of inhaled and exhaled SF6
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concentrations, the participants were switched to breathing room air, until
the end-tidal concentration of SF6 in exhaled breath fell below 1/40th of
original concentration (for three consecutive breaths) when the test was ter-
minated. Custom software was then used to calculate Lung Clearance Index
(LCI) [74], Scond and Sacin [86].
At the School of Physics and Astronomy, University of Nottingham,
the volunteers underwent the 3He magnetic resonance (3He-MR) tests, per-
formed using a 0.15 T scanner. Upon arrival, the participant confirmed
that they had filled and understood the MRI safety form. The participant
was then placed into the scanner for two scans, in a supine position, the
first time to undergo three CPMG scans, and the second time to undergo
a gADC scan and then a STE scan. Between each set of scans there was a
wait of approximately 30 minutes. During each scan the patient was given
a bag containing 600 ml of 3He/He4 mixture to breathe in and hold until
the scan was complete. The longest scan time was 8 seconds. The first two
healthy controls, and the first seven patient volunteers entered the study
during the pilot phase, and only underwent the CPMG and gADC scans.
Custom software was used to calculate ADC values.
As discussed in section 4.1.1, it has already been found that ADC at
short-time scales has a strong positive correlation with the degree of lung
inflation, such that a volume-correction must be applied to the ADC values
calculated [98]. However the effect of lung inflation on long-time scale ADC
has yet to be checked. In order to investigate this relationship, a further 6
volunteers (3 Asthma, 3 Control) were recruited, who only underwent body
plethysmography at Glenfield Hospital, and the STE sequence at various
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lung volumes at University of Nottingham. To achieve different lung vol-
umes, the 3He/He4 mixture bag ( 0.5 L) was inhaled from either residual
volume (RV) or from function residual capacity (FRC), and then followed
by inhalation of various set sizes of air (0-1 L), before holding their breath
for the scan. The results of the body plethysmography were used for the
absolute values of RV and FRC.
Twenty-seven of the asthmatic patients also underwent a quantitative
Computed Tomography (CT) densitometry at a later date. These were ob-
tained using a Siemens Sensation 16 scanner at Glenfield Hospital, using
the following low dose protocol: 16 x 0.75 mm collimation, 1.5 mm pitch,
120 kVp, 40 mAs, 0.5 s rotation time, 500 mm scanning field, and dose
modulation off. Full inspiration and full expiration scans were obtained. A
B35f kernel was used to reconstruct the images, with a slice thickness of
0.75 mm and at 0.5 mm intervals. Quantitative analysis of lung densitome-
try was performed using Apollo image analysis software (VIDA Diagnostics,
Coralville, Iowa). The main parameters of interest were the expiration/in-
spiration ratio of mean lung density, a marker of expiratory air trapping [35],
and the fifteenth lower percentile of the inspiratory lung attenuation curve
(P15), a marker of emphysema [24].
5.4 Results
This work has been published in the Journal of Allergy and Clinical
Immunology [33].
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Statistical analysis was performed on all data, with Student’s t-test
for group comparisons, Tukey test for one-way analysis of variance (multiple
comparisons) with Mann-Whitney U test for continuous variables, Fisher’s
exact test or Chi-squared test for proportions, and the use of Pearson’s cor-
relation coefficient for investigating relationships between continuous vari-
ables.
5.4.1 Clinical and Demographic Data
Table 7 shows a selection of the demographic and clinical data collected
at Glenfield Hospital. The asthma group has been subdivided into Asthma
(L) and Asthma (H), according to whether they have normal or high Sacin,
the upper limit of Low Sacin being defined as the mean + 1.64 standard
deviations of the control group (L-Sacin ≤ 0.204 L−1 < H-Sacin). Each group
was well matched for age and sex. Evidence for suboptimal asthma control
was seen in the H-Sacin group, with ACQ-6 scores significantly higher than
the L-Sacin group. Additionally, evidence of refractory asthma was seen in
76% of the H-Sacin group (p<0.05 vs L-Sacin) according to the ATS criteria
[78], with the majority (n=16/17) having GINA treatment step 4-5 asthma
[19]. Out of the L-Sacin, only 45% showed evidence of refractory disease,
with patients belonging to the full spectrum of GINA treatment steps.
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Table 7: Demographic and Clinical Data
Showing the mean (standard error) values for each group.
Control Asthma (L) Asthma (H)
No. of volunteers (n) 17 20 17
Age (years) 56.5 (2.89) 53.3 (3.2) 60.3 (2.0)
Sex (% male) 40 46.7 66.7
Height (cm) 169 (2.70) 164.9 (2.6) 170.5 (1.9)
Weight (kg)† 74.5 (3.01) 75.3 (3.5) 93.2 (4.7)#
Body Mass Index (kg/m2)† 25.8 (0.8) 28.9 (1.3) 31.2 (1.4)##
Smoking Status
Never Smoke (%) 88 15 10
Ex-smokers (%) 12 25 7
Pack Years (median[range]) 0[0-2] 0[0-7] 0[0-8]
Age of Onset of Asthma
Symptoms (years) - 23.4 (5.0) 27.5 (5.3)
Duration of Asthma (years) - 23.4 (5.0) 27.5 (5.3)
Atopic Status (% positive) - 85 82
ACQ-6 Score† - 1.43 (0.26) 2.14 (0.22)
AQLQ(S) Score∗ - 5.61 (0.23) 4.95 (0.31)
Sputum Neutrophil Count (%) - 57.2 (6.0) 61.8 (7.1)
Sputum Eosinophil - 2.69 1.76
Count (%)+ (1.23-5.89) (0.76-4.04)
Blood Eosinophil
Count (x109/L) - 0.33 (0.04) 0.34 (0.07)
Daily Inhaled Corticosteroid
Dose (beclometasone
dipropionate equivalent)
Median (µg) - 1000 1600
Range (µg) - 0-2000 200-2000
Use of Long-Acting
Beta-Agonists (%) - 75 94
Regular Use of Oral
Prednisolone (%) - 20 35
Use of Leukotriene Receptor - 10 35
Anatagonist (%)
Use of a Methylxanthine (%)∗ - 10 41
Patients in Asthma Treatment
(Step 2:Step 3:Step 4:Step 5)∗ - 1:6:9:4 1:0:9:7
Refractory Asthma (%)∗ - 45 76
+ Expressed as geometric mean (95% confidence interval).
∗ Trends towards significant differences across or between groups (p < 0.1).
† Significant differences across or between groups (p < 0.05).
# Significant differences compared to healthy group (p < 0.05).
## Highly significant differences compared to healthy group (p < 0.01).
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5.4.2 Example MRI Data
The following are a selection of the data collected from the MR scans,
with an example from each study group (Control, Asthma L and Asthma
H).
Figure 45 shows the 1-dimensional Signal Profile collected from CPMG
scans on a single volunteer from each group (this data is used for weighting).
Figure 46 shows the 1-dimensional ADC Profile as calculated from the same
scans. Figure 47 shows the final histogram data from each of the scans,
which is used to get the weighted and un-weighted 13ms ADC values.
Figure 48 shows the raw Signal Intensity results from STE scans per-
formed on the same 3 volunteers. Figure 49 shows the calculated ADC values
against time for each STE scan.
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Figure 45: CPMG Signal Profiles
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(b) Asthma L Volunteer’s Results
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(c) Asthma H Volunteer’s Results
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Figure 46: CPMG ADC Profiles
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(b) Asthma L Volunteer’s Results
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(c) Asthma H Volunteer’s Results
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Figure 47: CPMG Histograms
0.06 0.08 0.10 0.12 0.14 0.16 0.18 0.20
0
5
10
15
20
25
30
35
 Full ADC: 0.1058 +/- 0.03135 cm^2 s^-1
 Left Lung ADC: 0.1038 +/- 0.03318 cm^2 s^-1
 Right Lung ADC: 0.109 +/- 0.02791 cm^2 s^-1
 Full Weighted ADC: 0.1335 +/- 0.01105 cm^2 s^-1
 Left Lung Weighted ADC: 0.1382 +/- 0.01068 cm^2 s^-1
 Right Lung weighted ADC: 0.1258 +/- 0.006272 cm^2 s^-1
 Full FW: 0.2963
 Left FW: 0.3197
 Right FW: 0.2561
 Full Weighted FW: 0.08276
 Left Weighted FW: 0.07729
 Right Weighted FW: 0.04987
 - Both Lungs 
 - Left Lung 
 - Right Lung 
 - Both Lungs Weighted 
 - Left Lung  Weighted 
 - Right Lung Weighted 
Lung Histograms for 2013-08-16\He-HG8-GD-Run1 & 2013-08-16\He-HG8-GD-Run2 & 2013-08-16\He-HG8-GD-Run3
ADC(cm^2 s^-1)
Co
un
ts
Co
un
ts
(a) Control Volunteer’s Results
0.06 0.08 0.10 0.12 0.14 0.16 0.18 0.20
0
2
4
6
8
10
12
14
16
18
 Full ADC: 0.1231 +/- 0.03363 cm^2 s^-1
 Left Lung ADC: 0.1241 +/- 0.0392 cm^2 s^-1
 Right Lung ADC: 0.1222 +/- 0.02689 cm^2 s^-1
 Full Weighted ADC: 0.1395 +/- 0.01632 cm^2 s^-1
 Left Lung Weighted ADC: 0.1492 +/- 0.01008 cm^2 s^-1
 Right Lung weighted ADC: 0.1253 +/- 0.013 cm^2 s^-1
 Full FW: 0.2731
 Left FW: 0.316
 Right FW: 0.2201
 Full Weighted FW: 0.117
 Left Weighted FW: 0.06757
 Right Weighted FW: 0.1037
 - Both Lungs 
 - Left Lung 
 - Right Lung 
 - Both Lungs Weighted 
 - Left Lung  Weighted 
 - Right Lung Weighted 
Lung Histograms for 2013-04-22\He-AG14-GD-Run1 & 2013-04-22\He-AG14-GD-Run2 & 2013-04-22\He-AG14-GD-Run3
ADC(cm^2 s^-1)
Co
un
ts
Co
un
ts
(b) Asthma L Volunteer’s Results
0.06 0.08 0.10 0.12 0.14 0.16 0.18 0.20
0
10
20
30
40
50
 Full ADC: 0.108 +/- 0.03051 cm^2 s^-1
 Left Lung ADC: 0.09681 +/- 0.02926 cm^2 s^-1
 Right Lung ADC: 0.1201 +/- 0.02702 cm^2 s^-1
 Full Weighted ADC: 0.127 +/- 0.009306 cm^2 s^-1
 Left Lung Weighted ADC: 0.1206 +/- 0.004344 cm^2 s^-1
 Right Lung weighted ADC: 0.1334 +/- 0.008527 cm^2 s^-1
 Full FW: 0.2824
 Left FW: 0.3023
 Right FW: 0.225
 Full Weighted FW: 0.07329
 Left Weighted FW: 0.03602
 Right Weighted FW: 0.06394
 - Both Lungs 
 - Left Lung 
 - Right Lung 
 - Both Lungs Weighted 
 - Left Lung  Weighted 
 - Right Lung Weighted 
Lung Histograms for 2013-02-27\He-AG2-GD-Run1 & 2013-02-27\He-AG2-GD-Run2 & 2013-02-27\He-AG2-GD-Run3
ADC(cm^2 s^-1)
Co
un
ts
Co
un
ts
(c) Asthma H Volunteer’s esults
111
Figure 48: STE Signal Attenuation Plots
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Figure 49: STE ADC Plots
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5.4.3 Physiological, CT and MRI Data
The physiological results for each volunteer group are shown in Table 8.
Expiratory air trapping and flow limitation can be seen to be significantly
worse in the H-Sacin group than in the L-Sacin group. The H-Sacin group
also has significantly lower FEV1 (% pred.) than the L-Sacin group (69.3
compared to 90.9, with p<0.01), as well as a significantly higher residual
volume to total lung capacity ratio (RV/TLC) (48.3% compared to 38.2%,
with p<0.01) and significantly lower FRC (% pred.) (131.5% compared
to 103.7%, with p<0.01). No difference in the carbon monoxide transfer
coefficient (Kco) between the groups was seen.
The Magnetic Resonance results for each volunteer group are shown
in Table 9. The short time-scale ADC values are shown, alongside their
weighted (W), Volume Corrected (VC) and weighted and volume corrected
(VC W) values. It can be seen that correcting for volume greatly affects
the means for each group (as expected), whereas signal weighting has little
effect on the control group, but does impact the values of the asthma groups
(both reducing the mean and the spread). A significant difference was seen
in the weighted short time-scale ADC between the L and H groups, however
this difference was not seen in either of the Volume Corrected values.
Figure shows the shorter time-scale ADC results, and Figures 51-53
shows the long time-scale ADC results across all three groups. The measured
ADC at 1 second was found to be significantly higher in the H-Sacin group,
when compared to the healthy control group (0.024 compared to 0.017, with
p<0.05), and a trend towards a significant difference between the H-Sacin
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Table 8: Physiological, Computed Tomography Data
Showing the mean (standard error) values for each group.
Control Asthma (L) Asthma (H)
FEV1 (% pred.)∗∗∗∗ 97.7 (3.4) 83.9 (3.8) # 65.4 (4.8) ####,††
FEV1 Z Score ∗∗∗∗ -0.18 (0.23) -1.16 (0.26) # -2.28 (0.29) ####,†
FVC (% pred.)∗∗ 107.7 (3.7) 94.4 (2.9) # 91.6 (3.3) ##
FVC Z Score ∗∗ 0.53 (0.27) -0.42 (0.21) # -0.66(0.26) ##
FEV1/FVC
(% pred.)∗∗∗∗ 72.1 (1.7) 70.6 (2.5) 55.6 (3.3) ###,†††
FEV1/FVC
Z Score ∗∗∗ -1.03 (0.23) -1.23 (0.30) -2.73 (0.31) ###,††
FRC (L)∗∗ 3.67 (0.26) 3.08 (0.23) 4.28 (0.26) ††
FRC (% pred.)∗ 114.4 (6.2) 103.7 (6.7) 131.5 (6.2) ††
TLC (L) 6.92 (0.48) 5.70 (0.34) 6.77 (0.39)
TLC (% pred.) 109.8 (3.7) 103.3 (3.8) 109.5 (3.4)
RV/TLC (%)∗∗∗∗ 31.9 (2.2) 38.2 (1.9) 48.3 (2.3) ####,††
RV/TLC
(% pred.)∗∗∗∗ 88.3 (3.6) 104.8 (4.2) 125.6 (6.0) ####,††
VA/TLC (%)∗∗∗∗ 88.2 (1.8) 82.0 (1.9) 74.3 (1.9) ####,†
Kco
(mmol min−1 1.55 (0.06) 1.66 (0.06) 1.58 (0.07)
kPa−1 L−1)
LCI ∗∗∗∗ 7.34 (0.26) 7.43 (0.25) 9.59 (0.31) ####,††††
Scond (L−1) 0.029 (0.004) 0.054 (0.015) 0.068 (0.012)
Sacin (L−1)∗∗∗∗ 0.120 (0.012) 0.115 (0.011) 0.319 (0.026) ####,††††
MLD E/I - 0.83 (0.02) 0.89 (0.01)
P15 (HU) - -941 (5) -950 (5)
Significant differences across groups denoted:
∗(p < 0.05), ∗∗(p < 0.01), ∗∗∗(p < 0.001), ∗∗∗∗(p < 0.0001).
Significant differences compared to control group denoted:
#(p < 0.05), ##(p < 0.01), ###(p < 0.001), ####(p < 0.0001).
Significant differences between L and H groups denoted:
†(p < 0.05), ††(p < 0.01), †††(p < 0.001), ††††(p < 0.0001).
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Table 9: Magnetic Resonance Data
Showing the mean (standard error) values for each group.
Control Asthma (L) Asthma (H)
ADC 13 ms
(cm2 s−1) 0.136 (0.006) 0.136 (0.004) 0.145 (0.006)
ADC 13 ms (W)
(cm2 s−1) 0.135 (0.005) 0.129 (0.003) 0.141 (0.004)†
ADC 13 ms (VC)
(cm2 s−1) 0.146 (0.006) 0.146 (0.006) 0.150 (0.006)
ADC 13 ms (VC W)
(cm2 s−1) 0.144 (0.005) 0.136 (0.004) 0.146 (0.004)
ADC 1 s (cm2 s−1) 0.017 (0.001) 0.019 (0.001) 0.024 (0.002) ##
ADC 2 s (cm2 s−1) 0.012 (0.001) 0.013 (0.001) 0.016 (0.001) ##,†
ADC 3 s (cm2 s−1) 0.10 (0.001) 0.011 (0.001) 0.012 (0.001) ##,†
Significant differences across groups denoted:
∗(p < 0.05), ∗∗(p < 0.01), ∗∗∗(p < 0.001), ∗∗∗∗(p < 0.0001).
Significant differences compared to control group denoted:
#(p < 0.05), ##(p < 0.01), ###(p < 0.001), ####(p < 0.0001).
Significant differences between L and H groups denoted:
†(p < 0.05), ††(p < 0.01), †††(p < 0.001), ††††(p < 0.0001).
and L-Sacin asthma groups (0.024 compared to 0.019, with p=0.09). No
evidence for attenuation of acinar airway disease by systemic corticosteroid
therapy was seen, as for patients taking long-term oral corticosteroids (OCS)
the mean Sacin was 0.256 L
−1, the mean ADC at 13 ms (VC W) was 0.121
cm2s−1, and the mean ADC at 1 s was 0.023 cm2s−1, whereas those not
taking OCS had a mean Sacin of 0.191 L
−1 (p>0.05), a mean ADC at 13 ms
(VC W) of 0.131 (p>0.05) and a mean ADC at 1 s of 0.021 cm2s−1 (p>0.05).
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Figure 51: Box Plot of the 1 s ADC Values for Control and Asthma
Groups
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Figure 52: Box Plot of the 2 s ADC Values for Control and Asthma
Groups
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Figure 53: Box Plot of the 3 s ADC Values for Control and Asthma
Groups
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The CT densitometry data from the two asthma groups can be seen
in Figures 54-56. Evidence was seen of expiratory air trapping in the H-
Sacin group, and significantly raised MLD E/I when compared to the L-Sacin
group (0.89 compared to 0.83, with p<0.05). No difference in the inspiratory
P15 was seen across the groups. This suggests that a raised Sacin and CT
density-based assessments of emphysema are not associated in patients with
asthma.
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Figure 54: Quantitative CT Densitrometry
2 diagrams showing the assessment of expiratory air trapping in patients with low (A)
and high (B) levels of air trapping. The coloured spheres represent areas of lung >1 ml
in volume with an attenuation of expiratory scans of <-856 Hounsfield units.
Source: [33]
Figure 55: Box Plot of the MLD E/I Values for Control and
Asthma Groups
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Figure 56: Box Plot of the P15 Values for Control and Asthma
Groups
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5.4.4 Comparison of Physiological and Magnetic Resonance Data
The following Table 10 shows the correlations between the measured
ADCs and FRC (with Figures 57 and 60), Sacin (with Figures 58 and 61),
and MLD E/I (with Figures 59 and 62). The correlation between Sacin
and ADC at 13 ms (VC W) is quite weak (with R=0.40 and p<0.05) for
the asthma groups, whereas the correlation between Sacin ADC at 1 s is
quite strong (with R=0.65 and p<0.001) for asthma groups. Scond did not
correlate significantly with either 13 ms ADC (VC W) (with R=0.17 and
p=0.37) or 1 s ADC (R=0.10 and p=0.60). This indicates that the ADC
value is related only to the acinar component of ventilation heterogeneity.
No strong correlations were seen in the Healthy Control group.
Functional Residual Capacity percent predicted (FRC (% pred.)) cor-
relates strongly with both ADC at 13 ms (VC W) (R=0.65 with p<0.0005)
and ADC at 1 s (R=0.68, p<0.0001) as predicted, for patients with asthma.
Strong correlations were also found with the Mean Lung Density Expirato-
ry/Inspiratory ratio (MLD E/I) with both ADC at 13 ms (VC W) (R=0.77
with p<0.0001) and ADC at 1 s (R=0.72 with p<0.0001). No strong corre-
lations were seen in the Healthy Control group.
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Table 10: Pearson Correlation Values and p-values
13 ms ADC (VC W) 1 s ADC
against Control Asthma Control Asthma
Sacin R=-0.17, R=0.40, R=0.23, R=0.65,
p=0.55 p<0.05 p=0.5 p<0.001
Scond R=-0.04, R=0.17, R=-0.06, R=0.10,
p=0.89 p=0.37 p=0.86 p=0.60
FRC R=0.15, R=0.65, R=0.37, R=0.68,
(% pred.) p=0.65 p<0.0005 p=0.23 p<0.0001
MLD E/I - R=0.74, - R=0.72,
p<0.0001 p<0.0001
Figure 57: Scatter Graph of 13 ms ADC (VC W) against FRC.
CPMG ”Global Volume-corrected and Weighted” ADC at 13 ms plotted against FRC (% predicted) for
both Control and Asthma subjects.
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Figure 58: Scatter Graph of 13 ms ADC (VC W) against Sacin.
CPMG ”Global Volume-corrected and Weighted” ADC at 13 ms plotted against Sacin for both Control
and Asthma subjects.
0.100 
0.110 
0.120 
0.130 
0.140 
0.150 
0.160 
0.170 
0.180 
0.190 
0.200 
0 0.1 0.2 0.3 0.4 0.5 0.6 
A
D
C
  
1
3
m
s
 (
V
C
 W
) 
(c
m
2
 s
-1
) 
Sacin (L-1) 
Asthma 
Control 
Linear (Asthma) 
Figure 59: Scatter Graph of 13 ms ADC (VC W) against MLD E/I.
CPMG ”Global Volume-corrected and Weighted” ADC at 13 ms plotted against MLD E/I for Asthma
patients.
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Figure 60: Scatter Graph of 1 s ADC against FRC.
STE 1 s ADC plotted against FRC (% predicted for both Control and Asthma subjects.
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Figure 61: Scatter Graph of 1 s ADC against Sacin.
STE 1 s ADC plotted against Sacin for both Control and Asthma subjects.
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Figure 62: Scatter Graph of 1 s ADC against MLD E/I.
STE 1 s ADC plotted against MLD E/I for Asthma patients.
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5.4.5 Lung Inflation Magnetic Resonance Data
Figures 63 and Table 11 shows the ADC at 1 s relationship with lung
inflation, and Figures 64 and 65 along with Table 12 shows the ADC at
1 s relationship with percentage 3He, for three asthma patients and three
healthy control volunteers. Weak correlation between ADC at 1 s and lung
inflation was seen in the Asthma patients (R=0.67 with p<0.05), with only
a slight trend to a positive correlation seen in the healthy control volunteers
(R=0.39 with p=0.15). It was found that a 50% increase in lung inflation
would only result in a 3.7% increase in ADC in healthy volunteers, and a
4.5% increase in asthma patients. It was also seen that there was a significant
correlation between long time-scale ADC values and percentage 3He in the
lungs for the healthy control volunteers. However, the relationship was found
to be an inverse power, and so the ADC only changed significantly over the
regions of low 3He concentration. Over the range of typical usage (1.0-1.5%)
the ADC values varied only slightly.
Table 11: Pearson Correlation Values and p-values for Fractional
Volume and Fractional ADC at 1 s.
(ADCV - ADCFRC) / ADCFRC
against Control Asthma
(V-VFRC) R=0.39, R=0.67,
/VFRC p=0.15 p<0.05
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Table 12: Pearson Correlation Values and p-values for Percentage
3He and ADC.
3He Concentration (% by volume)
against Control Asthma
1 s ADC R=-0.66, R=-0.14,
(cm2s−1) p<0.01 p=0.68
1.5 s ADC R=-0.67, R=0.003,
(cm2s−1) p<0.005 p=0.99
2 s ADC R=-0.63, R=-0.14,
(cm2s−1) p<0.05 p=0.69
3 s ADC R=-0.65, R=0.065,
(cm2s−1) p<0.01 p=0.85
Figure 63: 1 s ADC and Lung Volume Relationship.
Fractional STE 1 s ADC values plotted against Fractional Volume, for 3 Control subjects and 3 Asthma
subjects.
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Figure 64: ADC and 3He Concentration Relationship for Control
Subjects.
STE ADC values plotted against Percentage 3He (by volume), from 3 Control subjects.
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Figure 65: ADC and 3He Concentration Relationship for Asthma
Subjects.
STE ADC values plotted against Percentage 3He (by volume), from 3 Asthma subjects.
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5.5 Discussion
This study found that the MBW parameter Sacin (using SF6 as the
tracer gas), is strongly associated with elevations in long time-scale ADC
(1 second) in patients with asthma. This association was not observed in
healthy subjects, and the elevations in long time-scale ADC could not be
reproduced purely by inflation of the lungs. This suggest that a specific
structural abnormality in the pulmonary acinus results in the elevations in
long time-scale ADC values , for patients with asthma.
There has been a number of previous studies investigating the clinical
significance of the acinar lesion in asthma. Farah at al found that Sacin
improvements after initiation of ICS treatment were independently associ-
ated with improvements in five-point ACQ scores [28], and that the asthma
control response to inhaled corticosteroid dose titration could be predicted
by markers of ventilation heterogeneity [29]. Thompson at al found that
asthma severity (as measured using the Global Initiative for Asthma treat-
ment steps) correlated with Sacin, and that asthma exacerbations and in-
creases in Sacin were associated [83]. It was observed in this study that
elevated Sacin was present primarily in refractory asthma (approximately
75% of cases) and in severe asthma (GINA 4-5). Although this may reflect
a higher prevalence of severe and refractory asthma in the study population,
H-Sacin asthma group had significantly higher proportions of patients with
refractory asthma than the L-Sacin group. No similar association was found
with conductive ventilation heterogeneity marker Scond. These observations
may suggest that conventional pharmacotherapy will struggle with the aci-
nar abnormalities highlighted by the SF6 MBW parameter Sacin in patients
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with asthma. This is hypothesis is supported by a recent interventional
study, that showed no significant effect on Sacin in patients with asthma was
observed when standard ICS treatment was swapped to small particle ICS
treatment [42], although more large and appropriately powered intervention
studies are required to confirm this hypothesis.
The diffusion of 3He in an acinar airway is more restricted in the trans-
verse direction than longitudinally, such that the shorter time-scale ADC
measurements (such as at 13 ms) are more sensitive to the airway radius
than to the airway branch length, and respectively longer time-scale ADC
measurements are more sensitive to network properties of the acinar airways,
with higher ADC values being associated with more inter- and intra-acinar
connections. Using an anatomically realistic asymmetrically dichotomous
model of the acinus, simulations have been performed that calculated long
time-scale ADC values of the same order as those observed experimentally
in healthy volunteers [88]. When intra-acinar collateral channels were added
to the model, it produced significantly increased values of the simulated long
time-scale ADC [89]. Long time-scale ADC can increase with both airway
branch length, as it allows greater longitudinal displacement along the air-
way axes, and with alveolar sleeve width, due to this causing a increase in
axial diffusion [87].
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It is important to address whether the Sacin and long time-scale ADC
correlation represents a true structural change in the pulmonary acinus, or
if it is driven by the presence of expiratory air trapping and hyperinflation
in asthma patients with high Sacin.
3He MR lung morphometry was used by
Hajari et al to assess the changes that occur in the acinar airways during lung
inflation in healthy subjects [41], in which they concluded that lung inflation
is primarily a result of alveolar recruitment, and only to a lesser extent by
the expansion of the alveolar ducts. They also found that the alveolar sleeve
depth actually decreased with increasing lung inflation. The expansion of
alveolar ducts is expected to increase short to intermediate time-scale ADC,
and has been shown that 13 ms ADC has a strong relationship with lung
inflation [98]. In this study, we found only minor effects of lung inflation
on long time-scale ADC. This suggests that the strong association between
Sacin and long time-scale ADC cannot be accounted for by hyperinflation
alone.
In this study strong correlations between the CT marker of expiratory
air trapping (MLD E/I) and both the shorter and longer time-scale ADCs
(13 ms and 1 s) were observed. This suggests that at the level of the aci-
nar airways there may be common structural abnormalities, and that this
may result in both expiratory air trapping and altered diffusion in the aci-
nar airways. Micro-CT of surgical lung biopsies or resected lung specimens
has been performed in patients with COPD [57], which provides a possi-
ble method of exploring the suggested structural abnormalities in asthma
patients. No evidence of emphysema in patients with asthma and a raised
Sacin was seen in this study, and neither P15 nor Kco was found to differ
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between the L-Sacin and H-Sacin groups. Normal Kco values in patients with
asthma was also observed in two previous studies [34,91], suggesting that the
alveolar-capillary membrane remains intact in asthma patients with elevated
Sacin.
5.6 Potential Limitations
This study has a few potential limitations. Firstly the majority of
the asthma patients were drawn from a secondary care centre, meaning
that the results may not match the general asthma population, such as a
higher proportion of patients with refractory asthma, or taking long-term
oral corticosteroids. The rationale for recruiting from the asthma centre
included optimisation of other factors, such as rhino sinusitis, treatment
non-adherence and psychological/behavioural issues, and as such were not
specifically identified from a treatment refractory cohort.
Additionally, the mean age of the asthma patients in this study may be
slightly older than the general asthma population, as may be the proportion
of males and females across the groups. The proportion of males in the
asthma group was 51.4%, which is much greater than the 36.9% proportion
published in a previous large difficult asthma cohort [43].
A further potential limitation stems from the sensitivity of the pul-
monary acinus to cigarette smoke that has been shown previously [90]. It
was therefore necessary that current and/or heavy smokers were excluded
from the recruitment for this study, despite that the general asthma pop-
ulation contains non-smokers and ex-smokers as well as current and heavy
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smokers. If current and heavy ex-smokers had been included then the smok-
ing associated acinar changes would have confounded the airway diffusion
measurements. Despite this, it still remains possible that differences in low-
grade cigarette smoke exposure may account for some of the proposed struc-
tural changes observed in this study.
Another limitation is seen in the results of the 13ms ADC values.
The weighting affects the results of the asthma groups more than the con-
trol groups. This may be due to the weighting suppressing areas with low
amounts of helium, which may correspond to areas of low ventilation (i.e ar-
eas of pathology). This should be investigated further before any conclusions
can be drawn.
Finally, the MR pulse sequences used do not provide three-dimensional
spatial information. Future studies incorporating more complex sequences
that provide three-dimensional spatial encoding could provide further in-
sights into the structural correlations of inert gas MBW parameters.
5.7 Conclusions
It was found that there appears to be an association between MBW
parameter Sacin and a structural abnormality in the pulmonary acinus, which
causes subtle alterations in diffusion within the acinar airways, in patients
with asthma. Additionally, the proportion of cases with refractory asthma
and a high Sacin was found to be significantly higher than the for asthma
patients with normal Sacin. This suggests that the lesion may be clinically
important, warranting further evaluation as this observation should only be
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regarded as exploratory.
Further longitudinal studies are required before the long-term prog-
nostic significance of acinar airway disease in asthma can be determined.
Additionally further studies will help to determine whether the acinar air-
way disease will be responsive to fine-particle inhaled or systemic therapies.
The affect of signal weighting on the short time-scale ADC values should also
be investigated further, to understand whether this step is beneficiary in re-
ducing the spread and error in the asthma groups, or whether it negatively
affects the results by suppressing areas of pathology.
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6 Leicester Royal Infirmary Cystic Fibrosis
Study
6.1 Background
It is estimated that in the United Kingdom 1 in every 2,500 babies
are born with cystic fibrosis, with more than 9,000 people living with the
condition [64]. Cystic Fibrosis is known to affect the mucus in the upper
airways, and leads to permanent infections. However, little is known whether
the hyper-viscous mucus and the infections and inflammations affect the
small airways.
There have been several studies that show the short time-scale ADC
of 3He or 129Xe is elevated in patients with emphysema [32, 50, 75, 76, 93,
105, 107], and in animal models of emphysema [10, 15, 56, 70] when com-
pared to healthy lungs. Additionally, the ADC was found to correlate with
quantitative histological measures of emphysema in a number of the studies,
such as mean linear intercept, mean alveolar internal area and mean chord
length [10,15,56,70,93,105].
6.2 Objectives
The aim of this study was to determine if there is any relationship
between the measurements of spirometry and body plethysmography, and
the measurements of the 3He-MRI CPMG and gADC sequences.
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6.3 Method
This was a collaborative study, with contributions from the following
people:
• Dr. Erol Galliard - Helped design the study. Co-Principal Investigator.
• Prof. John Owers-Bradley - Helped design the study. Co-Principal
Investigator. Assisted in performance of MRI scans.
• Dr. Caroline Beardsmore - Performed clinical lung function tests at
LRI. Recruited and screened patients and volunteers.
• Noor Al-Khathlan - Performed clinical lung function tests at LRI.
Performed statistical analysis of results.
• Ian Ball - Prepared 3He polarised gas and performed MRI scans. Cre-
ated gADC and CPMG MRI sequences.
• Dr. Niels Buhl - Provided theoretical input for formulation of the
gADC sequence and its analysis using the Yablonskiy model.
• Steven Hardy - Prepared 3He polarised gas and performed MRI scans.
Performed MRI raw data analysis. Performed statistical analysis of
results.
18 Cystic Fibrosis patients and 27 age matched healthy subjects were
recruited. All participants gave their written informed consent, and the
study was approved with alterations by the National Research and Ethics
Committee (East Midlands, Leicester, Project code: ’UHL 09580’ , REC:
’04/Q2501/114’).
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Participants first visited Leicester Royal Infirmary, before being trans-
ferred to the University of Nottingham via taxi. At Leicester Royal In-
firmary, after giving written informed consent, the participants underwent
spirometry, body plethysmography, and nitrogen washout tests. Then at
the School of Physics and Astronomy, University of Nottingham, the partic-
ipants underwent 3He magnetic resonance (3He-MR) scans, performed using
a 0.15T scanner. Upon arrival, the participant confirmed that they had
filled and understood the MRI safety form. The participant was then placed
into the scanner twice, in a supine position, the first time to undergo three
CPMG scans, and the second to undergo two gADC scans. Between scan
sets there was an approximately 30 minute wait. During each scan the pa-
tient was given a bag containing 500 ml of 3He/He4 mixture to breath in
and hold until the scan was complete. The longest scan time was 5 seconds.
6.4 Results
Statistical analysis was performed on all data, with Student’s t-test
for group comparisons, Chi-squared test for proportions, and the use of
Pearson’s correlation coefficient for investigating relationships between con-
tinuous variables.
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6.4.1 Example MRI Data
The following are a selection of the data collected from the MR scans,
with an example from each study group (Control and Cystic Fibrosis).
Figure 66 shows the 1-dimensional Signal Profile collected from CPMG
scans on a single volunteer from each group (this data is used for weighting).
Figure 67 shows the 1-dimensional ADC Profile as calculated from the same
scans. Figure 68 shows the final histogram data from each of the scans,
which is used to get the weighted and un-weighted 13ms ADC values.
Figure 69 shows the raw Signal Intensity results from gADC scans
performed on the same 2 volunteers. Figure 70 shows the signal corrected
b-space plots for each gADC scan, along with the fitting used to calculate
the R and h values.
6.4.2 Demographic, Physiological and Magnetic Resonance Data
Table 13 and Figure 71 shows a selection of the demographic and phys-
iological data collected at Leicester Royal Infirmary, alongside the Magnetic
Resonance data collected at the University of Nottingham. The two groups,
Control and CF, have been well age-matched, and roughly equal in female/-
male selection. It can be seen that there is very significant difference between
the Control and CF groups in the FEV1, FEV1/FVC, RV/TLC and LCI val-
ues. The short time-scale ADC values are shown, alongside their weighted
(W), Volume Corrected (VC) and weighted and volume corrected (VC W)
values. It can be seen that correcting for volume greatly affects the means
for each group (as expected), whereas signal weighting has little effect on
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Figure 66: CPMG Signal Profiles
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Figure 67: CPMG ADC Profiles
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Figure 68: CPMG Histograms
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Figure 69: gADC Signal Attenuation Plots
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Figure 70: gADC B-Space Plots
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the control group, but only slightly affects the CF group. It can also be
seen that there is a significant difference between the 13 ms ADC values
of the healthy and control groups, even after Volume Correction. A slight
significant difference in the Yablonskiy fitted R values, but no difference in
the Yablonskiy fitted H values.
Table 13: Demographic, Physiological and Magnetic Resonance
Data
Showing the mean (standard error) values for each group.
Healthy Controls Cystic Fibrosis
No. of Participants 30 18
Age (years) 14.6 (1.4) 14.7 (2.3)
Sex (% male) 50.0 44.4
Height (cm) 151.3 (3.5) 145.0 (5.1)
Weight (kg) 49.9 (3.9) 43.8 (4.6)
FEV1 (L) 2.7 (0.22)
#### 1.8 (0.14)####
FEV1 (% pred.) 101.7 (1.9)
#### 79.0 (5.2)####
FVC (L) 3.03 (0.27)# 2.35 (0.21)#
FEV1/FVC 0.895 (0.029)
#### 0.762 (0.020)####
RV/TLC 28.2 (1.0)†#### 39.7 (2.8)####
LCI (L) 7.0 (0.23)#### 11.4 (0.35)∗####
Sacin (L
−1) - 0.169 (0.035)∗
13 ms ADC
(cm2s−1) 0.133 (0.003)### 0.116 (0.005)###
13 ms ADC (W)
(cm2s−1) 0.133 (0.003)### 0.115 (0.005)###
13 ms ADC (VC)
(cm2s−1) 0.143 (0.004)## 0.129 (0.005)##
13 ms ADC (VC W)
(cm2s−1) 0.143 (0.004)## 0.127 (0.005)##
H (µm) 237 (6) 245 (7)‡
R (µm) 457 (9)## 431 (8)‡##
† Only taken on 29 participants.
∗ Only taken on 17 participants.
‡ Only collected on 14 participants.
Trends and significant differences between groups denoted:
#(p < 0.1), ##(p < 0.05), ###(p < 0.01), ####(p < 0.001).
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Figure 71: Box Plot of the 13 ms ADC and R-H Values for Control
and Cystic Fibrosis Groups
(a) CPMG ADC Values at 13 ms.
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6.4.3 Comparison of Physiological and Magnetic Resonance Data
Table 14 and Figures 72 to 77 show that there is very little or no signif-
icant correlation between the 3He-MRI results and the clinical physiological
data. A slight correlation is seen between Age and the R/H values for the
Control group, but that correlation is not seen in the CF group.
Table 14: Pearson Correlation Values and p-values
13 ms ADC (VC W) R‡ H‡
against Control CF Control CF Control CF
LCI
r=0.17, r=-0.13, r=0.06, r=-0.15, r=-0.04, r=0.12,
p=0.39 p=0.61 p=0.72 p=0.61 p=0.83 p=0.69
Age
r=-0.11, r=0.45, r=0.66, r=0.31, r=-0.61, r=-0.35,
p=0.56 p=0.06 p=8x10−5 p=0.27 p=0.0003 p=0.22
FEV1
r=0.30, r=-0.39, r=-0.26, r=-0.44, r=0.21, r=0.52,
p=0.11 p-0.11 p=0.16 p=0.08 p=0.25 p=0.06
13 ms
- -
r=0.19, r=0.74, r=-0.23, r=-0.70,
ADC (VC W) p=0.33 p=0.002 p=0.24 p=0.005
‡ Only collected on 14 of the 18 CF participants.
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Figure 72: Scatter Graph of 13 ms ADC (VC W) against FEV1.
CPMG ”Global Volume-corrected and Weighted” ADC at 13 ms plotted against FEV1 (% predicted)
for both Control and Cystic Fibrosis subjects.
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Figure 73: Scatter Graph of 13 ms ADC (VC W) against Age.
CPMG ”Global Volume-corrected and Weighted” ADC at 13 ms plotted against Age for both Control
and Cystic Fibrosis subjects.
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Figure 74: Scatter Graph of 13 ms ADC (VC W) against LCI.
CPMG ”Global Volume-corrected and Weighted” ADC at 13 ms plotted against LCI for both Control
and Cystic Fibrosis subjects.
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Figure 75: Scatter Graph of Calculated R and H against FEV1.
Yablonskiy Calculated R and H plotted against FEV1 (% predicted) for both Control and Cystic
Fibrosis subjects.
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Figure 76: Scatter Graph of R and H against Age.
Yablonskiy Calculated R and H values plotted against Age for both Control and Cystic Fibrosis
subjects.
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Figure 77: Scatter Graph of R and H against LCI.
Yablonskiy Calculated R and H plotted against LCI for both Control and Cystic Fibrosis subjects.
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6.5 Discussion
Short time-scale ADC is mainly sensitive to changes in acinar airway
radius. An increase in the acinar airway radius reduces the restriction to
the transverse displacement of the 3He and results in an elevated ADC.
This study found a slight significant decrease in the short time-scale ADC
in patients with Cystic Fibrosis, suggesting a decrease in the acinar airway
radius, which is consistent with the concept of infection and inflammation
occurring in the small airways [3]. However it is not enough to entirely
distinguish between a healthy and Cystic Fibrosis volunteer.
The parameters R and H from the Yablonskiy model represent the
acinar airway radius (R) and the alveoli width (H). This study found no
significant difference in R or H between the patients with Cystic Fibrosis
and the healthy controls. However it does show a significant association
with a short time-scale ADC, as expected, but only in the CF patients. It
also found a significant association between the Age of the healthy controls
and the R and H parameters, which suggests a broadening of the acinar
airway over time in adults. However, this pattern is not confirmed in the
short time-scale ADC result, which does not show a significant increase of
ADC with age.
6.6 Potential Limitations
Recently there has been some criticism over the timescales used with
the Yablonskiy model [67]. It is suggested that the model is not valid for dif-
fusion times greater than 2 ms, and these longer timescales may overestimate
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airway dimensions with a bias that increases with the diffusion time.
Another limitation is seen in the results of the 13ms ADC values.
The weighting affects the results of the asthma groups more than the con-
trol groups. This may be due to the weighting suppressing areas with low
amounts of helium, which may correspond to areas of low ventilation (i.e ar-
eas of pathology). This should be investigated further before any conclusions
can be drawn.
6.7 Conclusions
In conclusion, this study shows that short time-scale ADC decreases
in patients with Cystic Fibrosis, although it cannot be used to distinguish
between healthy volunteers and Cystic Fibrosis patients. Additionally, no
strong correlations were found between the measurements taken via standard
lung function tests (e.g. spirometry and body plethysmography) and the
measurements taken via hyperpolarised 3He diffusion MR.
The results also show that the R and H parameters are inconsistent,
which suggests that the model may not have been implemented correctly.
This concurs with the recent criticism of the model [67] when used with
diffusion times greater than 2 ms, as was used in this study. Future studies
are required, with various diffusion timescales both less than and greater
than 2 ms, to determine if the model is valid.
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The affect of signal weighting on the short time-scale ADC values
should also be investigated further, to understand whether this step is ben-
eficiary in reducing the spread and error in the CF group, or whether it
negatively affects the results by suppressing areas of pathology.
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7 129Xe Development
7.1 Background
For functional lung imaging using hyperpolarised gas MRI, the prime
imaging agent of choice for most researchers has been 3He rather than
129Xe [68]. The predominant reason for this preference is due to the stronger
signals attainable using 3He, as it can achieve higher levels of polarization
and has a higher gyromagnetic ratio. Other reasons include the lack of anaes-
thetic effects and the ease of access for researchers due to the availability of
polarisers (USA) or ease of gas transport (Europe).
However the rise in cost of 3He due to its limited supply coupled with
the falling costs of 129Xe and its unlimited natural supply has lead to many
researchers agreeing that 129Xe will ultimately emerge as the imaging agent
of choice. This shift has already been reflected with recent implementation
of new 129Xe studies and polarisers [1, 25,54,103].
Alongside the cheaper cost of 129Xe, it also has other benefits over 3He.
It is more robust once polarised, meaning the polarisation takes longer to
decay. It also has a slower diffusion time, making diffusion weighted mea-
surements easier to perform. Another benefit is that it is readily absorbed
through the porous membranes of the lungs into the bloodstream. This al-
lows for gas transfer studies, as well as dissolved-phase imaging of both the
lungs and the brain. However 129Xe is slightly toxic, having an anaesthetic
effect on the human body, so more care must be taken when performing
experiments involving human volunteers.
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7.2 Objectives
The main aim of this pilot study is to develop the scan sequences,
protocol and gas delivery in order to get MRI images of the human lungs that
are of a high standard, ready for future Clinical studies. The main focus was
on single ventilation images and dynamic ventilation images. A secondary
stage of this study is to develop diffusion weighted imaging sequences, and
dissolved-phase spectroscopy/imaging sequences.
7.3 Method
This was a collaborative study, with contributions from the following
people:
This was a collaborative study, with contributions from the following
people:
• Prof. Ian P Hall - Designed the study. Principal Investigator.
• Dr. Shahideh Safavi - Screened and volunteers. Performed clinical
monitoring of patients during scan visits.
• Sarah Wolfe - Recruited and screened volunteers. Performed clinical
monitoring of patients during scan visits.
• Dr Michael J Barlow - Qualified Manufacturer (QM). Produced 129Xe
polarised gas.
• Dr Brett Haywood - Qualified Assurer (QA) for 129Xe polarised gas.
Helped during performance of MRI scans.
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• Dr Arthur Hill - Qualified Person (QP). Responsible of cerfying each
batch of 129Xe polarised gas.
• James Thorpe - Assisted in performance of MRI scans. Will be per-
forming future MRI scans, as well as future raw data analysis and
results analysis.
• Steven Hardy - Performed MRI scans. Created broad-banded se-
quences. Performed raw data analysis. Performed analysis on results.
MHRA approval was granted for the Hyper-polariser system (Eu-
draCT: ’2013-004336-30’, CTA: ’03057/0061/001-0001’) and and ethical ap-
proval was granted for the pilot study by the NRES Committee (East Mid-
lands, Nottingham 2 Research Ethics Committee, NRES Ref: ’13/EM/0401’).
Only healthy subjects were recruited for the initial pilot stage. Before the
first scanning visit, each volunteer was subject to a screening visit, to deter-
mine their suitability for the study. This screening visit included Spirometry
lung function tests.
For each MRI scan visit (up to 4 visits in total per participant), the
participant underwent up to 4 scans, consisting of proton localiser and co-
registration sequences, followed by a single hyper-polarised 129Xe imaging
sequence. Initially the hyperpolarised 129Xe imaging scans were performed
using the bb2dfast sequence, however a Software update on the MRI scanner
required a new sequence to be designed (bbfgre) which was then used for
the rest of the scans performed so far.
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Tedlar bags of either 0.6 L or 1.0 L of hyperpolarised gas were pro-
duced for each scan using a GE 2000 Xe-Rb continuous flow polariser, with
a gas mixture of 2% naturally abundant Xe / 10% N2 / 80-87%
4He. The
hyperpolarised gas MRI was performed in a GE 1.5T Signa HDx MRI scan-
ner, using a RAPID biomedical 8-channel 129Xe chest coil. The typical
polarisation levels measured in the delivered bag was in the region of 8-12%.
7.4 Sequence Development
7.4.1 Flip-Angle Calibration
Usually the testing and calculation of the transmit gain necessary to
achieve the specific flip angles required by a scan is handled by the auto-
prescan functionality of the GE scanner. However, the use of the auto
pre-scan is undesirable for the Xenon scans. This is due to both the time
constraint of a breath-hold imaging (the auto-prescan can often take up to a
minute to complete), and the non-recoverable nature of the hyperpolarised
gas (each rf pulse reduces the amount of signal available for the next rf
pulse). Instead, the transmit gain / flip angle relationship must be calculated
beforehand for each sequence.
To establish the transmit gain / flip angle relationship, the sequences
were performed multiple times on many bags of hyperpolarised 129Xe (along-
side ∼20 kg of saline bags to load the coil). The sequences were performed
with the gradients turned off, and for a minimum of 64 RF excitations with
1 s spacing applied. T1 decay was assumed to be negligible for this short a
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time interval, meaning the signal S decays by:
S = S0cos(α)
n−1, (57)
where S0 is the initial signal, n is the excitation pulse index and α is the flip
angle. Using a non-linear least squares best fit algorithm, the flip-angle can
be calculated from the data (see Figure 78).
Figure 78: Flip Angle Measurement Examples
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Example data collected for flip angle calibration, along with the calculated best fit lines.
Starting from the top-most line, the calculated flip angles are: 4.0◦, 7.3◦, 13.6◦, and
30.9◦.
This process was repeated multiple times for each sequence, at varying
transmit gain settings, to establish the relationship between transmit gain
and flip angle. The results are shown in Figure 79. As can be seen each
scan routine has a different flip angle / transmit gain relationship. This is
due to the different sequences making use of various shapes and lengths of
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rf pulses. Using these results, the appropriate transmit gain can be found
for any desired flip angle for any of the sequences, allowing the sequence to
be prepared without the use of the auto-prescan.
Figure 79: Measured Flip Angle against Transmit Gain.
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The flip angle for the greatest signal-to-noise is different for hyperpo-
larised MRI than it is for normal proton MRI. Due to the non-recoverable
nature of hyperpolarised MRI, each subsequent excitation produces less sig-
nal than the previous. For the best signal-to-noise, a strong signal is required
at the centre of k-space. If the sequence is taken centre-out (as for bbfgre),
this is not a problem and much larger flip angles can be used. However if the
sequence is taken sequentially (as for bb2dfast), a much smaller flip angle
must be used, to preserve as much of the signal as possible for the centre of
k-space. Figure 80 shows the theoretical maximum signal available for each
excitation for various flip angles. From this a flip angle of 5.5◦ was chosen
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for bb2dfast to give the most signal at the centre of k-space (64 acquisitions).
Figure 80: Normalised Signal against Excitation Number for
Various Flip Angles
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A graph showing the theoretical measurable signal against excitation number, for
various Flip Angles. Assuming negligible T1 and T2 decays.
7.4.2 Measuring the Signal-to-Noise Ratio
One way to compare the relative quality of the MRI images is to com-
pare the raw data’s Signal-to-noise ratio (SNR). The signal to noise ratio
can be calculated using the following equation:
SNR =
(Asignal
Anoise
)2
, (58)
where A is the root mean square (RMS) amplitude over an area of interest,
in this case the signal and noise areas. The RMS amplitude for an area of
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interest can be calculated as:
A =
√√√√ 1
n
(
n∑
i=1
S2i ) (59)
where n is the number of points in the area of interest, and S is the signal
strength of each point. The area of interest for the signal of each set of raw
data is the middle half of each of the acquisitions, with the area of interest
for noise being the rest of the data. Figure 81 shows the areas of interest
using an example acquisition.
Figure 81: Sample Acquisition, Highlighting Noise and Signal Areas
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A graph showing a single example acquisition, with the area-of-interest for noise
highlighted red, and the area-of-interest for signal highlighted green.
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7.4.3 Initial Images
The first initial images were taken using the bb2dfast sequence, inher-
ited from The University of Sheffield. During this stage, it was important to
get the brightest image possible for proof-of-concept, and as such the ma-
jority of the scans were implemented with the slice gradient turned off, so
that the whole of the lungs is excited with each rf pulse. The initial images
were taken in both axial (Figure 82) and coronal planes (Figure 83).
Figure 82: Initial Axial Lung Images
(a) Gas partially inhaled before
scan start.
(b) Gas inhaled fully before scan
start.
Axial In-Vivo images taken using the bb2dfast sequence, with the slice gradient
switched off, on the same healthy volunteer, using a 0.6 L bag of ∼10% polarised 129Xe
gas. FOV = 48 cm, Res = 128x128, Te = 4.2 ms, Tr = 9 ms, Flip Angle = 5.5◦. Raw
SNR Left Image: 1.4, Right Image: 7.02
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Figure 83: Initial Coronal Lung Image
(a) Gas partially inhaled before
scan start.
(b) Gas inhaled fully before scan
start.
Coronal In-Vivo images taken using the bb2dfast sequence, with the slice gradient
switched off, on a healthy volunteer, using a 0.6 L bag of ∼10% polarised 129Xe gas.
FOV = 48 cm, Res = 128x128, Te = 4.2 ms, Tr = 9 ms, Flip Angle = 5.5◦. Raw SNR
Left Image: 1.55, Right Image: 2.28
7.4.4 New Sequence Images
The new sequence bbfgre differs from the initial sequence bb2dfast
in a few aspects, but the one of main importance is that it takes the k-
space acquisitions from the centre-out. This allows use of much larger flip
angles, and hence delivers a higher signal-to-noise ratio. Figure 84 shows a
comparison of the two sequences.
163
Figure 84: Sequence Comparison Images
(a) bb2dfast Sequence (b) bbfgre Sequence
Coronal In-Vivo images taken using the bb2dfast and bbfgre sequences, with the slice
gradient switched off, on the same healthy volunteer, using a 1 L bag of ∼5.6% and
∼5.9% polarised 129Xe gas respectively. bb2dfast: FOV = 48 cm, Res = 128x128, Te =
4.2 ms, Tr = 9 ms, Flip Angle = 5.5◦. bbfgre: FOV = 48cm, Res = 128x128, Te = 5
ms, Tr = 7.5 ms, Flip Angle = 20◦. Raw SNR Left Image: 1.88, Right Image: 7.65
As can be seen in Figure 84, the new bbfgre sequence is considerably
brighter than the original bb2dfast sequence. Analysis of the raw data found
that the SNR of the bb2dfast image was 1.9, whereas the bbfgre image was
7.7, a 4-fold increase.
7.5 Ventilation Images
7.5.1 Repeatability
In a research setting, an experiment must be repeatable if its results
are to be trusted. In a clinical setting, a test must be reliably consistent
if it is to be used for diagnosis or exploration. It is therefore important to
make sure the sequences could reliable and repeatably get the same results
(for the same subjects).
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Figure 85: Scan Repeatability (Volunteer 1)
Coronal In-Vivo images taken using the bbfgre sequence, with the slice gradient
switched off, on a healthy volunteer over three visits. Top Left scan was taken on the
first visit, using 0.6 L of ∼9.0% polarised 129Xe gas, the remaining scans were taken
across the other 2 visits, using a 1 L bag of ∼9.6%, ∼9.3%, ∼9.5% polarised 129Xe gas
respectively. Scans were started after the volunteer had inhaled the bag and taken a
second ’flushing’ breath. FOV = 48 cm, Res = 128x128, Te = 5.0 ms, Tr = 7.6 ms, Flip
Angle = 20◦. Raw SNR Top Left Image: 15.30, Top Right Image: 17.03, Bottom Left
Image: 16.67, Bottom Right Image: 13.99.
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Figure 86: Scan Repeatability (Volunteer 2)
Coronal In-Vivo images taken using the bbfgre sequence, with the slice gradient switched
off, on a healthy volunteer over two visits. Left scan was taken on the first visit, using 1
L of ∼7.45% polarised 129Xe gas, the other scan was taken on the second visit, using a 1
L bag of ∼9.8% polarised 129Xe gas. Scans were started after the volunteer had inhaled
the bag and taken a second ’flushing’ breath. FOV = 48 cm, Res = 128x128, Te = 5.0
ms, Tr = 7.6 ms, Flip Angle = 20◦. Raw SNR Left Image: 20.97, Right Image: 34.84.
Figures 85 and 86 shows the results from two different volunteers, both
attending multiple visits, undertaking an ’infinite slice’ version of bbfgre (i.e.
the slice gradient was turned off, so signal was seen from the full thickness
of the target).
Four ’infinite slice’ scans were taken over the three visits for the first
volunteer (Figure 85). As can be seen the images are almost identical, with
details such as the 2 shadow lines on the lower part of the patient’s right
lung (image left) visible in all 4 images. This shadow is likely to be due to
the gaps between the different lobes of the lung. Similar SNR values were
seen across all four images.
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Two ’infinite slice’ scans were taken over two visits for the second
volunteer (Figure 86). Unlike with the previous volunteer, no matching
details can be seen between the two images, other than the overall shape.
This may be due to the mis-match in SNR (21.0 vs 34.8), which in turn
is most likely a product of the varying 129Xe polarization level between the
scans (∼7.45% vs ∼9.8%).
Overall there has been some evidence of repeatable image quality (par-
ticular in the first volunteers images), however two small a sample size has
been collected so far to make any true conclusions.
7.5.2 Finding the Minimum Slice Thickness
The initial scans performed using bb2dfast and bbfgre were taken as
’infinite slice’, i.e. the slice gradient was turned off to maximise the SNR.
However, for greater information individual sliced images of the lungs are
desired. This raises a problem, as the thinner the slice, the less signal there
is available to create the image, lowering the SNR. Hence the minimum slice
thickness, that still produces usable images, needs to be found.
Figure 87 shows the thickest of the sliced images performed. Each slice
was 5.0 cm thick, with a 1.0 cm gap between each slice. The raw data SNR
for each image was 13.3, 7.9 and 1.9 respectively. Some detail can be seen
at this point (such as the Trachea and Bronchi in the upper right image),
however some blur is still visible at the edges, due to the thick slice size.
Overall the images are still bright enough to see clearly over the background
noise.
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Figure 87: Initial Sliced Images - 5 cm Slice Thickness
Coronal In-Vivo images taken using the bbfgre sequence, on a healthy volunteer, using a
1 L bag of ∼9.5% polarised 129Xe gas. The scan was started after the volunteer had
inhaled the bag. FOV = 48 cm, Slice Thickness/Spacing = 5.0/1.0 cm Res = 128x128,
Te = 5.0 ms, Tr = 7.6 ms, Flip Angle = 20◦. Raw SNR Top Left Image: 13.29, Top
Right Image: 7.93, Bottom Image: 1.89
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Figure 88: Initial Sliced Images - 2.5 cm Slice Thickness
Coronal In-Vivo images taken using the bbfgre sequence, on a healthy volunteer, using a
1 L bag of ∼9.4% polarised 129Xe gas. The scan was started after the volunteer had
inhaled the bag. FOV = 48 cm, Slice Thickness/Spacing = 2.5/0.5 cm Res = 128x128,
Te = 5.0 ms, Tr = 7.6 ms, Flip Angle = 30◦. Raw SNR Top Left Image: 7.69, Top
Middle Image: 5.26, Top Right Image: 3.09, Bottom Left Image: 2.63, Bottom Right
Image: 1.50.
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Figure 88 shows slices of 2.5 cm each, with a 0.5 cm gap between
each slice. The raw data SNR for this set was 7.7, 5.3, 3.1, 2.6 and 1.5
respectively. There is a lot more detail seen in these images, such as the
shadow due to the major blood vessels visible in the top middle image, the
top of the trachea in the top right image, and the shadowing on the lung in
the bottom right image (which was most likely due to the gaps between the
lobes of the lung). The images are still reasonably bright and visible against
the background noise.
Figure 89 shows the thinnest slice thickness performed so far. Each
slice was 1.0 cm thick, with a 0.5 cm gap between each slice. The raw data
SNR for each image was 2.10, 2.74, 2.14, 1.82, 1.71, 1.63, 1.68, 1.67 and
1.63 respectively (starting top left, left to right). Again detail is visible in
these image, such as the upper airways (middle image), major blood vessels
(middle left), and impressions from the rib cage (bottom middle and bottom
left). The background noise is more prominent in these images, even though
the flip angle was increased to 35◦. This may be the minimum slice thickness
achievable, that is still capable of producing clear enough images.
7.5.3 Proton Co-Registration
Proton co-registration scans were taken alongside some of the 129Xe
scans. These co-registration scans were taken just before the 129Xe scans,
and consist of the same slice thickness, and slice positions. The volunteers
were asked to inhale, to the best of their knowledge, the same amount of
room air that they would of 129Xe gas.
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Figure 89: Initial Sliced Images - 1.0 cm Slice Thickness
Coronal In-Vivo images taken using the bbfgre sequence, on a healthy volunteer, using a
1 L bag of ∼9.5% polarised 129Xe gas. The scan was started after the volunteer had
inhaled the bag. FOV = 48 cm, Slice Thickness/Spacing = 1.0/0.5 cm Res = 128x128,
Te = 5.0 ms, Tr = 8.4 ms, Flip Angle = 35◦. Raw SNR, Staring from Top Left, across
then down: 2.10, 2.74, 2.14, 1.82, 1.71, 1.63, 1.68, 1.67, 1.63.
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Figure 90: Xenon-Proton Overlay Images - 2.5 cm Slice Thickness
Coronal In-Vivo 129Xe bbfgre scan (alpha-red) overlaid onto a corresponding Proton
co-registration scan (black and white).Performed on a healthy volunteer, using a 1 L
bag of ∼9.4% polarised 129Xe gas. The 129Xe scan was started after the volunteer had
inhaled the bag. Proton Scan: FOV = 48 cm, Slice Thickness/Spacing = 2.5/0.5 cm
Res = 128x128, Te = 5.0 ms, Tr = 7.6 ms, Flip Angle = 30◦. 129Xe Scan: FOV = 48
cm, Slice Thickness/Spacing = 2.5/0.5 cm Res = 128x128, Te = 5.0 ms, Tr = 60.0 ms,
Flip Angle = 30◦.
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After taking both scans, the proton co-registration scan can then be
compared to the 129Xe scan, by overlaying the 129Xe scan images onto the
proton co-registration scan images, using a image manipulation programme
(such as GIMP). Figures 90 and 91 are two such examples.
Figure 91: Xenon-Proton Overlay Images - 1.0 cm Slice Thickness
Coronal In-Vivo 129Xe bbfgre scan (alpha-red) overlaid onto a corresponding Proton
co-registration scan (black and white).Performed on a healthy volunteer, using a 1 L
bag of ∼9.5% polarised 129Xe gas. The 129Xe scan was started after the volunteer had
inhaled the bag. Proton Scan: FOV = 48 cm, Slice Thickness/Spacing = 1.0/0.5 cm
Res = 128x128, Te = 5.0 ms, Tr = 70 ms, Flip Angle = 30◦. 129Xe Scan: FOV = 48
cm, Slice Thickness/Spacing = 1.0/0.5 cm Res = 128x128, Te = 5.0 ms, Tr = 8.4 ms,
Flip Angle = 35◦.
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As can be seen in these two examples, the 129Xe scan agrees with the
proton co-registration scan, in that where there is signal in the proton scan,
there is a reduction in signal from the Xe scan. Notable cases are in the
top middle and right images of Figure 90 and the top right image and entire
middle row of Figure 91, where signal from blood vessels can be seen in
the proton images, with a corresponding decrease of signal in the Xenon
images. This helps boost confidence in the reliability of the 129Xe scans in
their ability to highlight areas with decreased gas penetration.
One major drawback of this technique is that the proton co-registration
images do not always match the 129Xe images, due to the volunteer inhaling
a different amount, or in a different manner. The best technique would
be to perform both scans at the same time, such that the proton scan is
taken in the same breath hold as the 129Xe image. However with the current
system available, this is not feasible. Another improvement would be to
use a Tedlar bag filled with medical air, to the same volume as that of the
129Xe bags, to better help the volunteer match the same inhalation volume.
This is more feasible, but may require a slight adjustment to the currently
approved study protocol.
7.5.4 Inhalation Methods
An important aspect of the scan protocol to develop during the pilot
stage is the 129Xe inhalation method. The main concern is that the 129Xe
gas may become ’trapped’, and not reach the areas of interest (such as the
furthest lung pathways). A second inhalation of room air following the 129Xe
inhalation (henceforth referred to as a ’flushing’ breath) may help move the
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129Xe gas from the upper airways and trachea down into the lungs.
Several scans were performed, on multiple healthy volunteers, to help
determine the effect of both the flushing breath and the original 129Xe bolus
size on the resulting images. Figure 92 shows pairs of images, each pair taken
on the same volunteer on the same visit, using the same scan settings, one
with and one without a flushing breath. As can be seen, where no flushing
breath was used, the upper airways are often visible. Without the upper
airways are not visible. This suggests that the flushing breath does indeed
clear the upper airways of 129Xe. It is also evident that the cross-sectional
size of the lung is smaller in the non-flushing breath image, which may be
the cause of the higher SNR in those images (as the 129Xe is concentrated
into a smaller region). The size of the lung also changes between images in
a different manner for each volunteer (i.e getting longer rather than wider,
vice versa, or a mix), perhaps suggesting that each volunteer inhales differ-
ently (e.g. primarily breathing via contraction of the diaphragm, or via the
expansion of the rib cage, or both).
Figure 93 shows two images, taken on the same volunteer on two sep-
arate visits, using the same scan settings but with two different 129Xe bolus
sizes. A flushing breath was used for both images. There appear to be no
obvious differences in the two scans, other than that the SNR for the images
increased slightly (raw SNR was 15.3 and 16.7 respectively). This is most
likely due to the flushing breath, that makes the total inhalation volume
approximately the same, regardless of the initial bolus size.
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Figure 92: Comparison of Flushing to no Flushing Breath
Coronal In-Vivo images taken using the bbfgre sequence, with the slice gradient switched
off, using a 1 L bag of ∼9.1% polarised 129Xe gas. Each pair of images was taken on the
same volunteer. The left scans were started after the volunteer had inhaled the bag and
taken a flushing breath, the right scans were started after the volunteer inhaled the bag.
FOV = 48 cm, Res = 128x128, Te = 5.0 ms, Tr = 7.6 ms, Flip Angle = 20◦. Raw SNR,
starting top left, across then down: 12.10, 30.61, 18.37, 36.81, 20.64, 50.54.
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Figure 93: Comparison of Different Bolus Sizes
Coronal In-Vivo images taken using the bbfgre sequence, with the slice gradient
switched off, on the same healthy volunteer. The left image was taken using a 0.6 L bag
of ∼9.0% polarised 129Xe gas, and the right image was taken using a 1 L bag of ∼9.3%
polarised 129Xe gas. The scan was started after the volunteer had inhaled the bag and a
second ’flushing’ breath. FOV = 48 cm, Res = 128x128, Te = 5.0 ms, Tr = 7.6 ms, Flip
Angle = 20◦. Raw SNR Left Image: 15.30, Right Image: 16.67.
7.5.5 Dynamic Ventilation Images
Of some interest to the medical field is the manner in which the gas
flows into the lungs during inhalation. To view this, a dynamic ventilation
scans can be performed, where successive 129Xe scans are preformed during
the inhalation of the gas. So far this method has been tested twice, once
using the old scan sequence, with a low flip angle, and once with the new
scan sequence, using a higher flip angle.
Figure 94 shows the dynamic ventilation images collected using the old
bb2dfast scan sequence, with a small flip angle of 5.5◦. As can be seen, at
the start of the scan only the upper airways are seen, then the lungs become
progressively brighter as more gas flows into them, before fading away as
the polarisation decreases with each successive scan. Figure 95 shows the
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Figure 94: bb2dfast Dynamic Lung Images
Coronal In-Vivo images taken using the bb2dfast sequence, with the slice gradient
switched off, on a healthy volunteer, using a 1 L bag of ∼8.2% polarised 129Xe gas. The
scan was started, and then the volunteer slowly inhaled the bag. Each image was taken
approximately 1.2 seconds apart. FOV = 48 cm, Res = 128x128, Te = 4.2 ms, Tr = 9
ms, Flip Angle = 5.5◦. Raw SNR, Staring from Top Left, across then down: 1.04, 1.26,
1.55, 1.98, 2.38, 1.89, 1.44, 1.21, 1.13.
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Figure 95: bbfgre Dynamic Lung Images
Coronal In-Vivo images taken using the bbfgre sequence, with the slice gradient
switched off, on a healthy volunteer, using a 0.6 L bag of ∼9.4% polarised 129Xe gas.
The scan was started, and then the volunteer slowly inhaled the bag. Each image was
taken approximately 1.0 seconds apart. FOV = 48 cm, Res = 128x128, Te = 5 ms, Tr =
7.5 ms, Flip Angle = 20◦. Raw SNR, Staring from Top Left, across then down: 0.91,
1.39, 1.74, 1.80, 1.37, 1.37.
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dynamic ventilation images collected using the new bbfgre scan sequence,
with a larger flip angle of 20◦. As can be seen, at the start the image only
shows the upper airways. However, unlike the first set of images, the entirety
of the lungs do not come into focus through the successive images. This is
due to the higher flip angle, which reduces the polarisation of the previously
excited gas significantly, so the majority of the signal only comes from the
freshly inhaled gas, and such only the upper airways and upper lung are
seen.
It is clear that more development is needed, to find the optimum flip
angles to give the required balance of gas penetration and SNR to highlight
ventilation to whichever the required areas of interest are within the lungs
(such as upper or lower airways).
7.6 Dissolved-Phase Spectroscopy and Imaging
An attractive quality of 129Xe is the possibility of dissolved-phase imag-
ing, of the brain, lung or other regions, due to its solubility in blood and lipid-
rich tissue [82]. The dissolved-phase resonance of Xenon has been measured
to be shifted by approximately 200 ppm from the gas-phase resonance [60],
which makes it feasible for both phases to be collected in a single acquisition.
However, before more complex imaging and spectroscopy sequences can be
developed and used to exploit this quality, it must first be confirmed that
the system can detect the dissolved-phase signal, as there is much less signal
available then there is for the gas-phase.
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Figure 96: Initial Dissolved State 129Xe Spectra
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Results from three spectroscopy scans on two different volunteers, normalised to the gas
signal. Scan parameters: No. of Samples = 4096, No. of Acquisitions = 25, Tr = 360
ms (blue) 528 ms (red/green), Spectral Width = 7042 Hz (blue), 8928 Hz (red/green).
Two dotted lines have been placed to represent the expected dissolved state peaks, the
left most line representing the expected ∼196 ppm lung parenchyma peak [62], and the
right most line representing the expected ∼216 ppm red blood cell peak [62].
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A simple pulse and acquire routine (with all gradients switched off),
was used to provide FID spectra, with the pulse/acquire frequency targeted
at 200 ppm above the gas-phase frequency. Figure 96 shows the results from
two such scans, where the multiple acquisitions have been averaged together,
and the x-scale adjusted to center on the gas-phase peak. As can be seen,
the multiple peaks associated with dissolved-state Xenon (from Xenon in the
lung parenchyma and the red blood cells) have been successfully detected, at
the expected positions. The first two experiments performed (red and green
lines), were done with a longer Tr time and wider spectral width, which may
be the cause of the reduced signal strength for the dissolved peaks in those
images. This will be investigated in future scans, in order to help maximise
the signal strength of the dissolved peaks.
After the success of detecting the dissolved-phase signal, an image of
the dissolved-phase 129Xe in the lungs was attempted. The volunteer was
instructed to breath in the 129Xe gas, with a secondary flushing breath, as
usual. Then the bbfgre sequence was used to produce 5 images (each taken
approximately 2 seconds apart during the breath hold). Figure 97 shows
the 5 images, alongside an image constructed from a simple average of the
other 5. A higher level of Gaussian filtering then usual was used during
image reconstruction, to increase the SNR of the images (at an expense to
the resolution). As can be seen, there is a faint image of the lungs, in the
majority of the images, that becomes more apparent in the last averaged
image.
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Figure 97: Initial Dissolved-Phase Images
Coronal In-Vivo dissolved-phase images taken using the bbfgre sequence, with the slice
gradient switched off, on a healthy volunteer, using a 1 L bag of ∼9.0% polarised 129Xe
gas. The scan was started immediately after the volunteer inhaled the bag and a second
flushing breath. Each of the 5 image was taken approximately 2.0 seconds apart. FOV
= 48 cm, Res = 64x64, Te = 1.5 ms, Tr = 15 ms, Flip Angle = 30◦. The final bottom
right image is a simple average of the other 5 images.
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7.7 Conclusions and Future Work
As has been shown, good progress has been made to develop hyperpo-
larised 129Xe MRI techniques at the University of Nottingham. Good lung
images have been achieved, down to 2.5 cm thick slices. Initial images have
been taken of both dynamic ventilation and dissolved-phase 129Xe in the
lungs.
However, more development is still required. The SNR of the dissolved-
phase images and raw spectroscopy is very low, and needs to be improved
upon. The settings for the dynamic ventilation images still need optimis-
ing for the required areas of interest (upper or lower airways). Proton co-
registration protocol could be improved upon, to help ensure consistent and
reliable matching between the proton images and corresponding 129Xe im-
ages.
To help with SNR, an order for a new 129Xe MRI chest coil has been
placed. This new coil is of a ’life-jacket’ style design, allowing the transmit
and receive coils to be closer to the area of interest, a method that may
provide higher SNR images. The new design also allows volunteers of larger
sizes to participate, and increases volunteer comfort. A second generation of
the 129Xe polariser is also in construction, which once completed and its use
approved, should be able to provide higher levels of polarisation for future
work.
184
8 Conclusions
The work presented in this thesis has investigated both hyperpolarised
gas MR spectroscopy and imaging, with both 3He and 129Xe gas. Hyper-
polarised 3He MRI was used to investigate and and provide information on
both asthma and cystic fibrosis, alongside conventional lung function tests
and quantitative CT. Hyperpolarised 129Xe MRI techniques were developed
within the department, in preparation for future human studies within the
department, which included initial dissolved-state spectroscopy and imag-
ing.
In the first study, the Chiesi study, the nature of the acinar airway
involvement in asthma sufferers was investigated, using 3He hyperpolarised
diffusion MRI, alongside quantitative Computer Tomography densitometry
and standard lung function tests. The hypothesis, that asthma patients
with an elevated MBW Sacin parameter would manifest altered long-range
diffusion, was tested by comparing the parameter with the short and long
time-scale ADC values, as measured from the hyperpolarised MRI. An asso-
ciation was found, between Sacin and the long time-scale ADC (1 second) in
patients with asthma, that was not observed in healthy patients, and failed
to be reproduced purely by inflation of the lungs. This suggested that a spe-
cific structural abnormality may exist in the pulmonary acinus, that results
in elevations of the long time-scale ADC values in asthmatics. However these
observations where purely exploratory, and such further longitudinal studies
are required before the significance of acinar airway disease in asthma can
be determined. The results of this study was published in the Journal of
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Allergy and Clinical Immunology.
In the second study, the Leicester Royal Infirmary Cystic Fibrosis
study, the relationship between spirometry measurements and 3He MRI
short time-scale ADC values and Yablonskiy model R and h measurements
were investigated in patients with Cystic Fibrosis. The short time-scale ADC
values were found to decrease in patients with Cystic Fibrosis, although it
was not significant enough to use a distinguishing parameter between healthy
volunteers and Cystic Fibrosis patients. Inconsistencies were found in the
R and h parameters, that may be explained by the recent criticism of the
model for diffusion times greater than 2 ms. Future studies are required to
determine if the model is valid, before the technique can be repeated as an
investigative tool for exploring diseases such as Cystic Fibrosis.
In both of the above experiments, signal weighting was used on the
calculation of the short time-scale ADC. However concerns have been raised,
especially on the results of the LRI CF study, on whether this leads to a
suppression of the areas of pathology. Further studies are required into this,
as if the suppression is not an issue, the signal weighting has shown potential
in reducing the statistical spread and error in the results for short time-scale
ADC.
The final result section looked into the initial results of the pilot study
to develop hyperpolarised 129Xe MR imaging at the University of Notting-
ham. Although some good initial lung images have been acquired, including
dissolved-state images, further study and development is required to achieve
reliable and repeatable quality images, as required for both studies and
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clinical work. The quality of the images collected at the University of Not-
tingham is expected to increase with the arrival of the new ’life-jacket’ style
129Xe MRI chest coil and the second generation 129Xe polariser (capable of
higher levels of polarisation), both of which are due to arrive within the
upcoming year.
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A Appendix
A.1 1H Scan Protocols
Protocol 1 Protocol 2
Pulse Pulse
Sequence: FSE-XL Sequence: FSE-XL
PSD Name: fse-xl PSD Name: fse
P Weight: 40 P Weight: 40
P Postition: Supine P Postition: Supine
P Entry: Head first P Entry: Head first
Coil: BODY Coil: BODY
Plane: Axial Plane: Axial
Mode: 2D Mode: 2D
No. of Te: 1 No. of Te: 1
Te: Min Full (13.1) Te: Min Full (21.3)
Tr: 460 Tr: 720
Echo train Echo train
length: 32 length: 32
Flip Angle: 90 Flip Angle: 90
Freq: 512 Freq: 512
Phase: 512 Phase: 512
NEX: 4 NEX: 3
No. Slices: 42 No. Slices: 42
Slice Slice
Thickness: 10 Thickness: 10
Spacing: 1.5 Spacing: 1.5
FOV: 48 FOV: 32
Bandwidth: 31.25 Bandwidth: 15.63
Est. SAR: 1.4 Est. SAR: 0.9
Peak SAR: 2.8 Peak SAR: 1.8
Scan Time: 42:50 Scan Time: 49:40
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Protocol 3 Protocol 4
Pulse Pulse
Sequence: FSE-XL Sequence: SPGR
PSD Name: fse-xl PSD Name: bb2dfast
P Weight: 60 P Weight: 60
P Postition: Supine P Postition: Supine
P Entry: Head first P Entry: Head first
Coil: BODY Coil: BODY
Plane: Coronal Plane: Coronal
Mode: 2D Mode: 2D
No. of Te: 1 No. of Te: 1
Te: Min Full (13.1) Te: Minimum (2.7)
Tr: 460 Tr: 11.0
Echo train
length: 32 Flip Angle: 180
Flip Angle: 90 Freq: 128
Freq: 512 Phase: 128
Phase: 512 NEX: 40
NEX: 8 No. Slices: 46
Slice
No. Slices: 42 Thickness: 10
Slice
Thickness: 10 Spacing: 1.5
Spacing: 1.5 FOV: 32
FOV: 48 Bandwidth: 15.63
Bandwidth: 31.25 Nuclei: 1
Est. SAR: 1.7 Est. SAR: 1.7
Peak SAR: 3.4 Peak SAR: 3.4
Scan Time: 42:47 Scan Time: 43:15
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Protocol 5
Pulse Sequence: SPGR
PSD Name: bb2dfast
P Weight: 60
P Postition: Supine
P Entry: Head first
Coil: BODY
Plane: Coronal
Mode: 2D
No. of Te: 1
Te: Minimum (2.7)
Tr: 11.0
Flip Angle: 180
Freq: 128
Phase: 128
NEX: 40
No. Slices: 46
Slice Thickness: 10
Spacing: 0.5
FOV: 48
Bandwidth: 31.25
Est. SAR: 1.7
Peak SAR: 3.4
Scan Time: 43:15
cfxfull: 0
cfyfull: 0
cfzfull: 0
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A.2 129Xe Scan Protocols
Protocol 1 Protocol 2
Pulse Pulse
Sequence: SPGR Sequence: SPGR
PSD Name: bb2dfast PSD Name: bb2dfast
P Weight: 60 P Weight: 60
P Postition: Supine P Postition: Supine
P Entry: Head first P Entry: Head first
Coil: RAPID BOTH Coil: RAPID BOTH
Plane: Axial Plane: Axial
Mode: 2D Mode: 2D
Imaging Imaging
Options: Fast Options: Fast
Nucleus: 129 Nucleus: 129
Te: Minimum (4.8) Te: Minimum (4.8)
Tr: 14.0 Tr: 14.0
Flip Angle: 180 Flip Angle: 180
Freq: 512 Freq: 512
Phase: 512 Phase: 512
NEX: 8 NEX: 8
No. Slices: 42 No. Slices: 42
Slice Slice
Thickness: 20 Thickness: 20
Spacing: 1.5 Spacing: 1.5
FOV: 48 FOV: 48
Phase FOV: 1 Phase FOV: 1
Bandwidth: 31.25 Bandwidth: 31.25
Est. SAR: 0.0 Est. SAR: 0.1
Peak SAR: 0.1 Peak SAR: 0.2
Scan Time: 40:11 Scan Time: 40:11
xmtaddScan: 60.206 xmtaddScan: 60.206
TG: 186 TG: 186
Effective Flip Effective Flip
Angle: 45 Angle: 45
cfxfull: 0
cfyfull: 0
cfzfull: 0
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Protocol 3 Protocol 4
Pulse Pulse
Sequence: GRE Sequence: GRE
PSD Name: bbfgre PSD Name: bbfgre
P Weight: 50 P Weight: 50
P Postition: Supine P Postition: Supine
P Entry: Head first P Entry: Head first
Coil: RAPID BOTH Coil: RAPID BOTH
Plane: Axial Plane: Axial
Mode: 2D Mode: 2D
Imaging Imaging
Options: Fast Options: Fast
Nucleus: 129 Nucleus: 129
Te: Minimum (2.8) Te: Minimum (2.8)
Tr: 5.7 Tr: 15.0
Flip Angle: 90 Flip Angle: 90
Freq: 64 Freq: 64
Phase: 64 Phase: 64
NEX: 1 NEX: 1
No. Slices: 90 No. Slices: 90
Slice Slice
Thickness: 5 Thickness: 5
Spacing: 0.0 Spacing: 0.0
FOV: 48 FOV: 48
Phase FOV: 1 Phase FOV: 1
Bandwidth: 31.25 Bandwidth: 31.25
Est. SAR: 0.03 Est. SAR: 0.03
Peak SAR: 0.07 Peak SAR: 0.05
Scan Time: 00:38 Scan Time: 00:50
xmtaddScan: 0.0 xmtaddScan: 0.0
TG: 150 TG: 150
Effective Flip Effective Flip
Angle: 30 Angle: 30
cfxfull: 0
cfyfull: 0
cfzfull: 0
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